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Patient Specific Radiation Doses from Projection Radiography
Images: Improving the accuracy of low dose radiation calculations
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B.S. Mathematics Education, University of New Mexico, 1999
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ABSTRACT
Due to an increase in regulatory scrutiny and medical facility accreditation
requirements to monitor patient radiation dose from diagnostic imaging
procedures, there is a growing necessity to determine and record accurate patient
radiation dose from diagnostic medical imaging procedures. Current methods of
patient dosimetry in diagnostic imaging are both extremely difficult and time
consuming, require large computing resources (such as Monte Carlo
computations), or lack accuracy due to using data based on homogenous
materials and “standard-man sized” anthropomorphic models.
This dissertation provides an algorithm that calculates a more accurate
dose using patient-specific projection radiographic images. The algorithm includes
measurements acquired during routine physics testing of the x-ray unit, data from
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two-view (Anterior-Posterior and Lateral chest) radiographic images, and accounts
for patient specific and body habitus.
The algorithm developed in this work uses formulas for calculating entrance
and exit dose utilizing a new dose correction factor. The dose correction factor is
based on the exposure index and average grayscale from radiographic images
specific to the subject and shows improved accuracy of traditional calculation
methods for entrance and exit dose calculations.
Measurements using optically stimulated luminescent dosimeters, physics
measurements on radiographic equipment, and Monte Carlo simulations were
used to test and develop the algorithm. This new algorithm uses the mean
radiographic image grayscale value over the region of interest and the reported
Exposure Index to create a correction factor to correct patient dose calculations.
The final product is an algorithm for calculating patient specific dose from AP and
lateral chest radiographs that is more accurate with less associated uncertainty
than current traditional dose calculation methods.
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1 Introduction
1.1 Necessity of Patient Radiation Dose Calculations
Recent attention to the rise in diagnostic imaging exams has caused an
increase in the scrutiny towards patient radiation dose. Although most of the
attention has been towards the escalation in computed tomography (CT)
examinations, the use of non-advanced imaging modalities (i.e., not CT, MRI,
nuclear medicine, or ultrasound) comprise the majority of all diagnostic imaging
procedures [1]. One study of 6 large integrated health systems reported that
between 1996 and 2010 there were 30.9 million imaging examinations performed,
of which 65% were from non-advanced imaging modalities [2]. Due to its
availability, speed and lower cost when compared to other imaging modalities,
projection radiography continues to be the most commonly ordered diagnostic
imaging exam [3], [4]. The chest radiograph in particular accounts for
approximately 45% of all projection radiography exams, consequently adding up
to over 150,000,000 chest radiographs performed in the U.S. annually [5].
In 2010, the International Atomic Energy Agency (IAEA) put forth an effort
to begin recording patient radiation doses from all diagnostic imaging procedures
[6]. In January of 2015, the Joint Commission, one of the foremost accrediting
bodies for health care organizations and programs in the United States, changed
their accreditation requirements to include tracking of patient radiation dose [7].
Although the push for patient radiation dose tracking stems from the increase in
computed tomography (CT) exams, the intent is to eventually track patient specific
radiation dose from all diagnostic imaging procedures. This creates an issue, in
1

that, even though projection radiography exams are the most common imaging
procedure, the patient-specific dose from these procedures is estimated with a
large uncertainty.

1.2 Radiation dose Risk Models
The Linear No-Threshold (LNT) model is currently still the most widely used
estimate of risk from radiation exposure. The absence of a lower threshold dose in
the LNT model leads to the interpretation that there is no amount of radiation that
is safe [8], [9]. Many professional societies, such as the American Association of
Physicists in Medicine (AAPM) and the Health Physics Society (HPS), recognize
that this model is flawed, especially at low radiation doses. The AAPM has stated
“Risks of medical imaging at patient doses below 50 mSv for single procedures or
100 mSv for multiple procedures over short time periods are too low to be
detectable and may be nonexistent” [10], [11]. The Health Physics Society has
stated “For doses below [50-100mSv] risks of health effects are either too small to
be observed or are nonexistent” [10], [12].
Current risk models for estimating risk of cancer induction and fatal cancer
induction, are primarily created using the Biological Effects of Ionizing Radiation
(BEIR) VII reports. These reports are generally based on data collected from
Japanese atomic bomb survivors, where doses were delivered to the whole body
and do not adequately account for the different type of exposures, dose rates, and
specific organ doses from medical imaging exams [10]. This data also leads to the
extrapolation of low dose radiation effects with a substantial level of uncertainty.
Risk models developed with these uncertainties are themselves left up to broad
2

interpretation. Inaccurate low dose calculations are then matched to clinical
outcomes that may not be associated with the actual doses at those levels [10],
[13], [14].
The LNT model and the arguments against using it lead to the same
conclusion: there is a need for more accuracy in the dosimetry of low dose radiation
imaging procedures. This project intends to improve the accuracy of low dose
radiation calculations by developing a method for calculating patient specific doses
for projection radiography exams.

1.3 Current Radiation Dose Calculation Methods
Current mathematical algorithms tend to rely on average patient sizes, or
phantom models, and do not account for specific patient differences, such as body
habitus, and how these differences may affect not only entrance skin dose (ESD),
but dose to specific radiosensitive organs such as lungs, breasts etc. The dose
estimates for the “average patient”, or standard-man phantom, do not bring us
closer to tracking patient specific doses from projection radiography exams. This
is due mainly to the fact that patient size, and body habitus, greatly influences the
amount of radiation dose a patient receives. Larger patient sizes not only serve to
increase the technique (kV and mAs) chosen for radiographic exams, but will also
affect the SID and field size needed to encompass all the anatomy.
The Exposure Index
New projection radiography systems attempt to address the concern for
patient dose by adding an Exposure Index (EI) to their readout. The initial
implementation of the EI was to give the technologist an idea as to the quality of
3

their images along with a general estimate as to the patient dose [15].
Unfortunately, each vendor initially started with a different method of calculating
and displaying the EI, thus making it impossible to accurately compare images and
estimated patient doses between various systems [16].
The EI has since evolved to become a standardized metric by which the
radiographers are given feedback on the quality of their image, as well as an
indirect measure of the exposure to the digital detector [16], [17]. The standardized
EI adopted by nearly all of the digital radiography vendors presents a linear
relationship between the detector exposure and the EI value as shown in equation
1-1 [18], [19].
𝐸𝐸𝐸𝐸 = 𝐶𝐶0 ∙ 𝑔𝑔(𝑉𝑉)

1-1

Where 𝐶𝐶0 is the calibration factor and 𝑔𝑔(𝑉𝑉) is an equipment-specific inverse

calibration function of the value of interest, 𝑉𝑉. 𝑉𝑉 is defined as the air kerma

detected at the image receptor under the relevant anatomy as determined by the
vendor specific processing algorithms [16], [20], [21].
It has been shown that the EI is a very effective QA tool for monitoring
correct use of equipment and tracking variations in detector dose [15], [19];
however, it is widely known that the EI cannot be directly used as a measure of
patient radiation dose due to the fact that patient specific factors are not taken into
account, such as body habitus and patient thickness [18]. Research has been
performed in order to calculate patient entrance exposure and entrance skin dose
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(ESD), based on the EI of various imaging systems [22], [23], however, these
methods assume an average patient size, or standard-man size phantom, and do
not accurately take into account varying patient size or body habitus.
Entrance Skin Dose
Historically, patient doses have been determined by first calculating the
entrance surface (or skin) dose (ESD), then applying various weighting factors in
order to obtain organ dose, or whole body effective dose [24]. The equation for
ESD is as follows:
𝑋𝑋 ∗ 𝑚𝑚𝑚𝑚𝑚𝑚 ∗ 𝐷𝐷2
𝐸𝐸𝐸𝐸𝐸𝐸 =
∗ 𝐵𝐵𝐵𝐵𝐵𝐵
[𝑆𝑆𝑆𝑆𝑆𝑆 − (𝑡𝑡 + 𝑏𝑏)]2

1-2

Where X is the x-ray tube output at a known distance, D. X is typically given
in units of dose (Gy) per milliamp-second (mAs). The mAs is the product of the
tube current and exposure time, which is chosen at the control console. SID is the
source to image detector distance, b is the detector to table top (or detector
housing face) distance. The patient thickness is given by the variable t [24]–[26].
The final variable is the back scatter factor (BSF), which are values usually found
in lookup tables produced by measurements with varying field size, HVL and kVp.
The BSFs are typically measured at the surface of a water phantom or
water similar material, such as Lucite or some other uniform tissue mimicking
material, and have shown differences of up to 10% when compared to each other
[27]–[29]. Additionally, BSF measured in uniform materials do not account for the
heterogeneous makeup of actual tissue [30]–[32]. It is readily apparent that this
5

basic equation does not take into account the quality, or penetrating power as
determined by the kVp and filtration, of the x-ray beam itself.
Stanton et al were able to demonstrate the dependence of BSF on the
composition of phantom, with differences of up to 10% between Lucite, tissue and
water [30]. This difference is attributed to the quality of the beam as well as the
nature of the tissue being irradiated. Without taking into account the beam quality,
the traditional calculations ignore the variation of radiation dose deposited in
differing tissues.
This method begins with typical ESD calculation
𝑋𝑋 ∗ 𝑚𝑚𝑚𝑚𝑚𝑚 ∗ 𝐷𝐷2
𝐸𝐸𝐸𝐸𝐸𝐸 =
∗ 𝐵𝐵𝐵𝐵𝐵𝐵
[𝑆𝑆𝑆𝑆𝑆𝑆 − (𝑡𝑡 + 𝑏𝑏)]2

1-1

Where X and D are obtained from previous physics measurements for the kVp
selected. mAs, SID, and t (patient thickness) are noted by the technologist. In this
step, the only information not readily available is the backscatter factor (BSF) [24]–
[26]. There are many sources of backscatter factor tables, and there is good
agreement between all of them. For this project, the tables created by PetoussiHenns et. al which compiles backscatter factors created by Monte Carlo methods
for various field sizes, various beam qualities (HVL) and materials (water, ICRU
tissue, and PMMA) [29] were used for the backscatter factor data.
Once the ESD is calculated, the exit dose is traditionally calculated by
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𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 = 𝐸𝐸𝐸𝐸𝐸𝐸 ∗ 𝑒𝑒 −𝜇𝜇𝜇𝜇

1-3

Where µ is average linear attenuation coefficient for the material of interest,
and d is the total thickness of the subject [33]. As will be discussed later, this
simplified calculation neglects to take into account any scatter contributions in the
calculation area of interest that may increase the dose.
Monte Carlo Modeling
Monte Carlo modeling has long been used to improve the accuracy of
patient dose calculations. Some limitations to using Monte Carlo codes for patient
specific dosimetry are the intensive processing times required, as well as the time
and effort required for those unfamiliar with programming to accurately set up a
simulation. In order to facilitate the use of Monte Carlo simulations, especially for
the clinical medical physicist, some companies have created “customizable”
programs that allow the user to make certain limited adjustments to the calculation,
without having to learn how to program. One such software program, the most
readily available, is PCXMC by the Radiation and Nuclear Safety Authority in
Finland (STUK) [34]. PCXMC allows the clinical end user to adjust the radiation
field size, the source to image distance, and the height and weight of the patient,
which it then attempts to model with a mathematical phantom (See Fig 1-1). Other
technical factors that need to be supplied by the end user are x-ray tube potential,
x-ray tube anode angle, filter material and thickness. This amount of information
appears to be the minimum needed in order to create a decent simulation.
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Figure 1-1: Screen capture of the PCXMC interface showing the mathematical model as
well as various user customizations.

There are noticeable limitations to the PCXMC software such as constraints
on

beam

characterization,

air

kerma

reference

points,

and

phantom

representation. In addition to only being able to model a nearly uniform radiation
field, the user defined beam is only capable of minor customizations, such as total
filtration rather than beam homogeneity, and air kerma at the “patient entrance”
rather than a fixed reproducible point which has been shown to result in variances
of up to 40% [35], [36]. However, the main limitation with PCXMC, as with most
other Monte Carlo simulations, is the use of a standard mathematical phantom
based on the “standard man” philosophy. These phantoms are rarely able to
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accurately represent the variations in size, shape, and body habitus of real
patients. Studies have shown that, due to the use of these standard mathematical
phantoms, calculated doses can differ from measured doses by 28-72% [37].

1.4 Lack of accuracy of patient dosimetry
Techniques published to date for attempting to estimate patient dose have
relied on average patient sizes, or phantom models, and do not account for specific
patient differences, such as body habitus, and how they may affect not only ESD
but dose to specific organs such as lungs, breasts etc. Ultimately, dose estimates
for the “average patient” do not provide an accurate solution to tracking patient
specific doses from projection radiography exams.
In order to improve the accuracy of the dose calculation, specifics of the
radiographic equipment in use, such as kV, mAs, Source-to-Image-Distance (SID),
x-ray beam quality, patient thickness and patient area irradiated need to be known.
Current Digital Radiography (DR) systems are capable of tracking nearly all of the
required elements (kV, mAs, SID, area irradiated) except for x-ray beam quality
and patient thickness. With little effort, patient thickness can be measured by the
technologist, or from the subsequent images, and beam quality can be determined
by the medical physicist at acceptance testing and verified annually during
equipment surveys or after major service or upgrade. Thus, all required
parameters to calculate patient specific dose are available.
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1.5 Proposed solution
The final product of this dissertation will provide a validated mathematical
algorithm to accurately calculate patient-specific doses based on physics
measurements and information available from digital radiographs with improved
precision over current methods.
The remaining chapters of this dissertation cover the following:
•

Chapter 2: Physics tests and data collection performed on the
radiographic unit.

•

Chapter 3: Methods for calibration and understanding of nanoDot
OSLD dosimeters is discussed.

•

Chapter 4: Discussion and testing of Monte Carlo code techniques
required to complete the development and validation of the
mathematical algorithm.

•

Chapter 5: Details of the experimental in situ measurements are
provided and discussed.

•

Chapter 6: Algorithm development and validation are detailed and
discussed in this chapter.

•

Chapter 7: This chapter presents the final conclusions, and future
work of this dissertation.
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2 Physics measurements
Before work can begin on the development of a dosimetry algorithm, it is
necessary to understand the imaging equipment being used. Since all radiographic
equipment can vary from manufacturer to manufacturer, or even more simply,
device to device, it is necessary for medical physicists to perform various
measurements on a regular basis to ensure consistency. The measurements
outlined below have either been standardized in the medical physics profession,
or are adapted from various reputable sources and are widely accepted by various
AAPM task groups [38]–[41].
1. Determine Air Kerma (AK) at a reference point for use in projection
radiography. This would entail:
a. Determine AK for various device settings such as kV mAs and focal
spot size
b. Measure AK at a reference point for various kV stations
c. Calculate the AK in mGy at the reference point, which will give an
AK/mAs (mGy/mAs) for each kVp at the reference point
2. Characterize the x-ray beam and radiographic unit by ensuring proper
functioning, as applicable, based on standards set forth by the American
College of Radiology, The American Association of Physicists in Medicine,
New Mexico State Regulations, and the Code of Federal Regulations. The
following measurements are typically performed with a commercially
available detector system. This would entail:
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i. Verification of the kV by measuring accuracy and
reproducibility of the kV
b. Measuring the first and second Half Value Layer (HVL) in order to
determine the homogeneity coefficient using narrow beam
geometry
c. Checking the exposure output and timer reproducibility of the
system
3. Exposure Index calibration check to ensure proper functioning within
manufacturer specifications.

2.1 Steps for determining Air Kerma at a reference point
The setup consists of a calibrated ion chamber placed with its center located
at the AK reference point (100 cm from the focal spot). The beam is well collimated
to cover the ion chamber (5x5 cm field) with only a small margin around the
chamber in order to conform to narrow beam geometry standards [42]. The
chamber is placed perpendicular to the x-ray tube axis in order to negate the heel
effect. There is sufficient space beyond the ion chamber (50 cm) to negate any
effects of backscatter [39], [42], which will be accounted for separately.
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Figure 2-1: a. Diagram of proper setup of air kerma measurement using ion chamber. b.
photograph of actual setup.

In addition to ion chamber measurements, it is now acceptable practice by
American Board of Radiology certified medical physicists to perform these, and
other measurements, using a solid state detector in addition to, or instead of, ion
chamber measurements [43], [44]. Therefore, after verification with a NIST
traceable ion chamber, most measurements were completed using either a
recently calibrated RadCal Accu-gold+ (Radcal, Monrovia, CA), or Raysafe X2
(Fluke Biomedical, Everett, WA) solid state detector system.
Measurements of AK in mGy (or exposure in Roentgen for later conversion
to mGy) are taken at a range of kVp stations. Table 2-1 shows the data collected
for various kVp stations on the GE Discovery XR656 radiographic unit located in
the University of New Mexico Hospital Radiology Department general x-ray room
13

1. The data collected consists of the set kV, the set mAs, measured kVp, and
exposure (mR). From these values it is possible to calculate the exposure per
milliamp-second (mR/mAs), the AK in mGy at the reference point, and finally the
Air Kerma (mGy) per mAs for each kVp at the reference point.
Table 2-1: Data collected at Air Kerma reference point using Radcal Accu-gold+
measurement system.
Set kVp
60
80
100
110
120
125
130

Set mAs
32
32
32
32
32
10
32

kVp measured
60.0
80.4
100.7
110.9
121.2
126.7
131.4

Exposure (mR)
91.62
172.1
269.2
322.5
378.8
125.9
438.5

mR/mAs
2.86
5.38
8.41
10.08
11.84
12.59
13.7

AK (mGy)
0.8026
1.507
2.358
2.825
3.318
1.103
3.841

AK/mAs (mGy)
0.025
0.047
0.074
0.088
0.103
0.110
0.120

The end result from the measurements is an Air Kerma per mAs (AK/mAs)
at selected kV stations. From the graph of the AK/mAs as a function of kV (Figure
2-2), the best fit can be solved for an AK/mAs at any kV setting of the system at
the given AK reference point.
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Figure 2-2 Graph depicting AK/mAs as a function of kV for the GE Discovery XR656
radiographic unit.

2.2 Characterization of the x-ray beam
X-ray beam characterization is performed to provide an understanding of
how the x-ray beam will interact with various tissues and phantoms due to
attenuation and scattering. Medical physicists characterize the x-ray beam using
procedures as described below to check the accuracy of the beam energy
(verification of kV), the reproducibility of the exposure and timer settings (mAs and
timer), and by measuring the 1st and 2nd half value layer in order to calculate the
homogeneity coefficient. The homogeneity coefficient describes the polyenergetic
character of the beam. A monoenergetic beam has a homogeneity coefficient of
1.0, whereas polyenergetic beams will be <1.0. Typical homogeneity coefficients
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of diagnostic x-ray beams are between 0.5 – 0.7 and can be used as description
of the stability and quality of the x-ray beam as it traverses the subject [45].
Verification of the kV was performed using the Radcal Accu-gold+ system
(Radcal, Monrovia, CA) to determine accuracy and reproducibility. Five exposures
were made at each of the desired kV stations. The five kV measurements were
then used to determine the reproducibility of the exposure (mR/mAs) and exposure
time (msec), as well as the accuracy of the kV indicator. The measured kV should
be within ±5% of the indicated value as is typical for diagnostic medical physics
testing procedures.

Table 2-2 kV accuracy of the GE Discovery XR656 radiographic unit. The percent
difference of the selected kV on the unit to the measured kV should be less than 5%.
kVp Set

60

80

100

110

120

125

130

kVp Obs.

60.0

80.4

100.7

110.9

121.2

126.7

131.4

% Diff.

0.0%

0.5%

0.7%

0.8

1.0%

1.4%

1.1%

Reproducibility is determined by the coefficient of variation from the five
measurements. A well calibrated x-ray unit should have a coefficient of variation
less than 0.05 [38].
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Table 2-3 Reproducibility of the exposure and exposure timer at 80kV for the GE Discovery
XR656 radiographic unit.

Measurement # Exposure (mR) Time (ms)
1
53.3
40.45
2
54.1
40.45
3
53.6
40.45
4
52.4
40.45
5
53.9
40.45
COV
0.01
0.00

The steps for determination of the first and second half value layer outlined
below closely follow the process described by several sources [38], [39], [42], [46].
Figure 2-3 details the setup for the HVL measurements.

Figure 2-3: a. Diagram depicting HVL measurement setup. Aluminum filters are attached
to the collimator. Scatter detected by the ion chamber is reduced due to the "back scatter buffer"
beyond the chamber, as well as the distance between the filters and the detector. b. Photograph of
actual setup.
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Place the 0.6cc calibrated ion chamber 100 cm from the x-ray tube focal
spot, leaving at least 50 cm beyond the ion chamber to minimize back scatter
contributions. The beam should be collimated to an area around the ion chamber
of approximately 5x5 cm, ensuring that the ion chamber is centered in this area
and perpendicular to the axis of the x-ray tube. The first exposures made are “free
in air” with no attenuating material (other than inherent filtration) between the ion
chamber and the x-ray tube. Exposures are made at each kV of interest with a
constant mAs setting, and the exposure in Roentgen (R) recorded. Attenuator
material is then placed at the face of the collimator in order to minimize any scatter
effects from the attenuator material. High-purity (99.9%) aluminum filters are used
as attenuator material. The thickness of the attenuator material shall be increased
by 1.0mm for each exposure, keeping the kV and mAs constant and the exposure
(R) is recorded. This process continues for each added aluminum filter until the
exposure measured is reduced to less than 25% of the exposure measured without
any attenuator material in place. Once this data is collected for every kV of interest,
the results are plotted with the exposure in Roentgen as a function of attenuator
thickness in mm.
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Figure 2-4 Example calculation of first and second Half Value Layer measurements and
calculation for GE Discovery unit for 80kVp.

The best fit line for this graph will give a logarithmic equation which can then
be solved for the 1st and 2nd HVL of the beam at a given kV. The homogeneity
coefficient is calculated by taking the ratio of the 1st to the 2nd HVL. The
homogeneity coefficient will be calculated for each kV of interest.
Table 2-4 first and second Half Value layer calculated for kV’s of interest on the GE
Discovery XR656 unit.

HVL 1 (mmAl)
HVL 2 (mmAl)
Homogeneity Factor

60 kV
2.65
5.76
0.46

80 kV
3.55
7.72
0.46

100 kV 125 kV
4.40
5.44
9.57
11.83
0.46
0.46

The above measurements were performed in accordance with industry
accepted equipment and techniques. If the radiographic equipment was found to
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be out of specification, or if any other issues were found, a service call would have
been placed and physics measurements repeated before continuing with data
collection.

2.3 Exposure Index calibration check
GE X-ray systems define the EI as the ratio between the median image
counts within the relevant anatomic region in the value of interest and the
uncompensated detector sensitivity:
𝐸𝐸𝐸𝐸 = 100[𝜇𝜇𝜇𝜇𝑦𝑦 −1 ] ∙

𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 [𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐]
𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐
𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 [ 𝜇𝜇𝜇𝜇𝜇𝜇 ]

2-1

The International Electrotechnical Commission defines the Median Count
as “the central tendency of the original data in the relevant image region” [20]. For
the GE x-ray system the relevant image region is defined as the anatomic region
which is identified from the specific image processing algorithm chosen at the
console. The detector sensitivity is an inherent property of the digital detector
based on its ability to convert x-ray photons to detected signal and is proportional
to counts/ µGy. Therefore, dividing the EI by 100µGy-1 is related to the measured
dose at the detector [21]. The detector sensitivity has a correction factor that can
be adjusted by service personnel during service calls, and therefore should be
checked to ensure proper reporting of the Exposure Index for imaging procedures.
The exposure index calibration check for the GE Discovery XR656
radiographic

system

is

performed

according
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to

the

manufacturer

recommendations [21]. The check entails placing the digital detector on the table
top, with an SID of 100 cm. No additional filtration, no grid are used. A 20 mm
Aluminum block provided by the manufacturer is placed on the face of the
collimator, which is fully open. Exposures at 80 kV and varying mAs stations are
performed. The digital detector is then replaced with the Radcal-Accugold+
detector and in the same geometry and filter setup. Exposure measurements are
repeated for each mAs station. The response of EI should be linear in relation to
the air kerma measurements at each mAs station.

Figure 2-5: Exposure Index and air kerma linearity check.

According to the manufacturer, the relationship between the air kerma and EI/100
when measured at calibration conditions should be 1 to 1 with an allowable
accuracy limit of 20% [21]. All recorded EI/100 to air kerma measurements show
accuracy to within 5%.
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3 nanoDot Calibration Methods
In order to validate the accuracy of the new dosimetry algorithm good
source of measured data for comparison was required. Monte Carlo modeling has
long been used to improve the accuracy of patient dose calculations, so it was
determined that Monte Carlo simulations would suffice in providing the necessary
data for validation of the new dosimetry algorithm. In order to accurately simulate
the dosimetry data, it was necessary to have a pool of measured data that could
be compared to the Monte Carlo simulation for accuracy and validity of the code.
Optically stimulated luminescent dosimeters (OSLD), specifically nanoDots
by Landauer, were the best choice to provide dose measurement data due to their
lower cost, re-usability, accuracy, stability and ease of use [47]–[49].

3.1 nanoDot Calibration
nanoDots are small disks (Diameter 5mm, 0.3mm thickness) of aluminum
oxide doped with carbon (Al2O3:C) in a dielectric crystalline structure, housed in a
thin 10mm x 10mm x 2mm plastic container.
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Figure 3-1: Landauer nanoDot optically stimulated luminescent dosimeter (OSLD)

The crystalline structure contains crystal-lattice imperfections that function
as electron or hole traps. When the nanoDots are exposed to ionizing radiation,
some electrons may gain enough energy to move to generate free electrons at a
higher energy level (towards the conduction band) and holes in an amount that is
proportional to the exposure, and are stored in the crystalline structure (figure 32). When the OSLD is exposed to light, the electrons will gain enough energy in
order to escape the trap and recombine with the hole. Since the electrons need to
move from a higher energy level to a lower level in order to recombine with the
hole, they must give off energy. The energy is emitted in the form of light at a
known wavelength (λ = 420nm) as the crystalline structure luminesces [48], [50].
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Figure 3-2: Diagram of OSLD. Incoming x-ray photons interact in with the crystalline
structure to create an electron-hole pair. Subsequent stimulation by light will allow the electron-hole
pair to recombine giving off energy as visible light.

The intensity of the detected luminescence is proportional to the absorbed ionizing
radiation dose [48], [51] and a proportionality constant based upon the
characteristics of the particular reader and the nanoDots. Therefore, it is necessary
to calibrate the microSTAR ii (Landauer) reader for the particular energy range of
interest.
The microSTAR ii reader used for this project was in clinical use at the
University of New Mexico Cancer Center, it was calibrated for MeV energies in use
at the Cancer Center. Therefore, upon receipt of the nanoDot dosimeters, the
reader needed to be calibrated for the diagnostic energy range of interest for the
measurements in this project. The calibration was performed under the guidance
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of Angelo Bergamo, PhD. who is responsible for the microSTAR ii system at the
UNM Cancer Center, and is familiar with the calibration process.
In order to perform the calibration, a diagnostic energy calibration kit was
purchased from Landauer. The calibration kit consists of six calibration nanoDot
OSLDs (QC dosimeters) that are exposed to doses ranging from 0 to 100,000
mrad (0 – 100cGy) obtained by the manufacturer at an energy of 80kV and HVL
of 2.9 mmAl. Following the instructions included with the microSTAR ii system [52],
a linear calibration curve is created for using the calibration nanoDots. The process
for creating the curve is as follows:
1. Place the 100,000 mrad QC dosimeter in the microSTARii reader and
analyze it ten times. It is required to remove the dosimeter between each
reading in order to account for any mechanical variations in positioning
or functioning of the reader drawer.
2. Records the counts as displayed for each reading.
3. Compute the coefficient of variation (CV = standard deviation/average
reading) for the data set. Ensure that the result is less than 2% per
manufacturer requirements. The resultant CV was 1.4%.
4. Next, analyze each QC dosimeter under the “Calibration” tab of the
microSTARii reader software under the corresponding calibration
selection (High-Dose or Low-Dose) as specified by the manufacturer
based on the known dose of each calibration dosimeter.
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5. After placing the calibration dosimeter in the tray, enter the known dose
for each dosimeter in the appropriate box and select “Read”. The system
will read the dosimeter three times and give the average dose.
6. Each dosimeter should be analyzed three times for a total of nine
readings at each dose level.
7. Once all dosimeters have been analyzed three times, click “Accept” to
end and store the calibration.
The calibration curve was then tested, as per the instructions, by reading
each QC dosimeter 4 times and taking the average of the 12 results. According to
the manufacturer, the average of the 4 readings of the QC dosimeters should be
within 2% of the known dose; which it was. This calibration process allows the
system to accurately create a linear calibration curve for doses less than 300 cGy
[51], [53] in the energy range of which is more than adequate for the diagnostic
imaging doses expected from this research.
In order to further test the accuracy of the microSTARii and nanoDot
system, the nanoDots were taken to an x-ray room along with 20.8 cm of
polystyrene blocks. Readings were taken using a 0.6cc calibrated ion chamber
used with the Radcal Accu-Gold system placed at the surface of the polystyrene
blocks as shown in figure 3-3. The ion chamber comparison is typical in the field
of medical physics to check the response and accuracy of new dosimeters.
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Figure 3-3: 0.6cc ion chamber placed on surface of polystyrene blocks.

The source to surface distance (SSD) from the focal spot of the x-ray tube
to the entrance of the polystyrene blocks was set to 101.6 cm. The x-ray field was
collimated to a 5x5cm square around the ion chamber. The ion chamber was then
irradiated with an 80kV beam at 2, 4, 8, 16 and 20 mAs. Dose was recorded at
each mAs station.
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Next, the ion chamber was replaced with a nanoDot keeping the rest of the
configuration the same (figure 3-4).

Figure 3-4: nanoDot placement on polystyrene blocks. The rest of the configuration
matches the ion chamber setup.

Fifteen different nanoDots were irradiated in this fashion. This experiment
was not only used to test the accuracy of the nanoDots and microSTAR ii system,
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but also to test the sensitivity of the nanoDots themselves. Therefore, fifteen
nanoDots were irradiated as shown in the following table.

Table 3-1 nanoDot readouts at varying mAs station and number of exposures.

nanoDot# mAs
1

2

# of
exposures
1

Dose readout
(mrad)
18.465

Average Dose corrected for
number of exposures (mGy)
0.185

2

2

2

32.019

0.160

3

2

3

48.471

0.162

4

4

1

33.862

0.339

5

4

2

59.895

0.299

6

4

3

88.642

0.295

7

8

1

59.447

0.594

8

8

2

126.964

0.635

9

8

3

178.985

0.597

10

16

1

122.181

1.222

11

16

2

235.829

1.179

12

16

3

344.793

1.149

13

20

1

163.547

1.635

14

20

2

302.027

1.510

15

20

3

459.973

1.533

The readings in table 3-1 were corrected by subtracting the initial readout
(pre-exposure) from the post-exposure readout before converting to milligray
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doses based on the number of associated exposures. This corrected data was
then graphed as shown in figure 3-5.

Figure 3-5: Graph comparing Ion chamber measurements on 20.8cm of polystyrene blocks
to nanoDots. nanoDots were exposed to 1, 2, or 3 exposures and then corrected and converted to
mGy doses for comparison.

From the graph in figure 3-5, the nanoDots have a response similar to that
of the air filled ion chamber, although they appear to not respond linearly. It was
also determined that exposing the nanoDot dosimeters multiple times improved
the accuracy of the measurement. Therefore, all subsequent measurements were
performed by exposing the nanoDots more than once for each measurement. The
number of exposures used were noted for each experiment for later correction.
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To explore the behavior of the nanoDots further, additional measurements
were made using higher mAs exposures. The nanoDots were cleared for a period
of 22 hours, and then read out again in order to obtain a pre-exposure correction
factor. The setup was the same as in Figure 3-5 above. The data from the second
experiment are shown in table 3-2.

Table 3-2: second experiment comparing readings from ion chamber and nanoDots.

mAs Ion chamber (mGy) nanoDot (mGy)
2

0.13

0.14

4

0.26

0.28

8

0.5

0.6

16

1.0

1.1

20

1.3

1.4

40

2.4

2.8

80

4.8

5.4

100

6.0

7.0

160

9.5

11.1

200

11.9

13.4

The accompanying graph shows similar results as in figure 3-5, where the
nanoDots behave similarly to the ion chamber, however not entirely linear.
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Figure 3-6: nanoDot and ion chamber comparison at 80kV and 2 - 200mAs exposures.

However, when comparing the response of the nanoDots as the mAs (and
therefore the dose) increases compared to the ion chamber, by normalizing to the
maximum dose for both, the agreement is much closer. Normalized doses for both
the ion chamber and the nanoDots are given in table 3-3 and graph of the results
in figure 3-7.
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Table 3-3 Comparison of dose response to increasing mAs for ion chamber and nanoDot
dosimeters

Set mAs Ion chamber normalized dose nanoDot normalized dose
2

0.01

0.01

4

0.02

0.02

8

0.04

0.04

16

0.08

0.08

20

0.11

0.10

40

0.20

0.21

80

0.40

0.40

100

0.50

0.52

160

0.80

0.84

200

1.00

1.00
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Figure 3-7 Comparison graph of data in Table 3-3

Response to changes of kV were also measured using the same setup as
in Figure 3-3. Clinically relevant kV stations were chosen at 60, 80, 100, 120 kV
for both ion chamber and nanoDot measurements and exposures were made at 4
mAs. Figure 3-8 shows the graph of the results of the varying kV measurements.
nanoDot measurements were performed again using 2 exposures per nanoDot at
the same kV and mAs setting. The nanoDot measurements were then corrected
for number of exposures and converted to milligray. As shown in the graph in
Figure 3-8 response of the nanoDots and the ion chamber are nearly identical.
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Figure 3-8: comparison of dose measurements using constant mAs and varying kV.

Varying the filtration of the x-ray beam can shift the beam spectrum and
also affect the response of certain detectors. Therefore, measurements were made
comparing the nanoDots to the ion chamber using a constant kV and mAs with a
changing amount of filtration. Table 3-4 lists the various filter combinations
available on the radiographic unit, along with the subsequent dose readings for the
ion chamber and the nanoDots.
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Table 3-4 Comparison of ion chamber and nanoDot response with changing filtration

Filter
number
1
2
3
4

Filter Combination
No added filtration
0.1mmCu +
1mmAl
0.2mmCu +
1mmAl
2mmAl

Dose ion chamber
(mGy)
0.65

Dose nanoDot
(mGy)
0.68

0.29

0.29

0.2

0.2

0.4

0.42

Figure 3-9 comparison of ion chamber and nanoDot response with changing filtration

In order to test the inter-variability of the nanoDots themselves, all nanoDots
were placed on a radiology light box for clearing. The radiology light box has an
average luminance of 1848 cd/m2, and all nanoDots were placed uniformly on the
illuminated surface for approximately 48 hours. 35 nanoDots were randomly
chosen and placed in the marked containers. An initial “zero” reading was taken of
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the 35 nanoDots on the microSTAR ii system. The setup for the exposures was
the same as in figure 3-3 above. Each nanoDot was individually irradiated at 80kV,
4mAs large focal spot, 3 exposures, and returned to its respective container. On
the Philips Digital Diagnost x-ray unit located at the UNM Outpatient Surgery and
Imaging Services clinic, an exposure at 80 kV with 4 mAs using the large focal spot
at the same distance the nanoDots are placed gives a dose reading of 0.273 mGy.
The nanoDots were stored for 18 hours in a locked file cabinet before final
readout. Although it is considered good practice that the nanoDots be read out
within 4 hours of exposure, the manufacturer allows for much later readout given
that they are stored in a location where they will not be exposed to bright light,
sunlight or additional radiation [51]. After 18 hours, the nanoDots were read out 4
times and converted to mrad dose as per usual with the microSTAR ii system. The
initial readings from pre-irradiation were subtracted and the results were then
divided by 3 (due to the 3 exposures). The final corrected readings, converted to
mGy, are given in table 3-5.
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Table 3-5: nanoDot variance readings.

nanoDot
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35

Pre-exposure
reading (mrad)
0.788
0.806
0.699
0.691
0.797
0.771
0.788
1.061
1.497
1.366
0.466
0.911
0.835
0.825
0.825
0.921
0.683
0.716
0.683
0.806
0.779
0.707
0.932
0.691
0.683
0.707
0.676
0.788
0.966
0.576
0.699
0.583
0.699
0.461
0.724

18 hours Postexposure read (mrad)
87.48
82.58
85.52
85.92
82.90
82.81
80.84
83.70
91.80
83.92
85.17
82.55
85.17
86.18
91.25
86.27
82.78
84.94
86.43
84.54
87.62
84.41
84.47
84.77
83.47
85.23
84.44
83.43
92.60
87.54
84.13
85.29
85.99
81.20
84.63
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Corrected
reading (mrad)
28.90
27.26
28.27
28.41
27.37
27.35
26.68
27.55
30.10
27.52
28.24
27.21
28.11
28.45
30.14
28.45
27.37
28.07
28.58
27.91
28.95
27.90
27.85
28.03
27.59
28.18
27.92
27.55
30.54
28.99
27.81
28.24
28.43
26.91
27.97

mGy
0.289
0.273
0.283
0.284
0.274
0.273
0.267
0.275
0.301
0.275
0.282
0.272
0.281
0.285
0.301
0.284
0.274
0.281
0.286
0.279
0.289
0.279
0.278
0.280
0.276
0.282
0.279
0.275
0.305
0.290
0.278
0.282
0.284
0.269
0.280

The coefficient of variation for the nanoDots was approximately 3.01%, and
the accuracy of the average dose was 3.02%, which is in agreement with
manufacturer specifications and results found in the literature of the nanoDots
having a dose accuracy within 5% [49], [54].

3.2 Polystyrene block testing
The purpose of this experiment was to obtain data for comparison to the
Monte Carlo simulation performed in GATE. Therefore, five nanoDots were used
at each measuring point (entrance, midline, and exit) and their readings were then
averaged in order to simplify any influence due to heel effect or other beam
anomalies.
For this test, a stack of uniform polystyrene blocks were used along with the
previously calibrated nanoDots. The individual blocks are 25.5 cm x 25.5 cm
square of various thicknesses. The polystyrene blocks were stacked 20.8 cm high
directly on the digital detector of the GE Optima radiographic unit. The x-ray tube
was placed at 100 cm source-to image-distance (SID). X-ray field size was
adjusted to 32 cm x 32 cm at detector face. A total of fifteen nanoDots were placed
on the phantom, 5 at the entrance, 5 midline at 10.4 cm and 5 at the exit of the
polystyrene stack. See figure 3-10 for phantom setup and position of the nanoDots.
The nanoDots were placed as close to in-line with each other at each depth as
possible. 4.5 mm copper BB’s were placed at the entrance side of the phantom
near the nanoDots for later identification in the x-ray images.
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Figure 3-10: Polystyrene phantom setup with nanoDot dosimeter placement.

Three exposures were made using 80 kV and 4 mAs. It was determined in
the prior nanoDot calibration testing that performing three exposures on the
nanoDots, and calculating the average dose, helped to ensure that enough
radiation dose was detected in the nanoDot for a more accurate readout. As with
all nanoDot measurements, an initial reading was performed on the nanoDots in
order to correct the measured dose with any remnant reading still present on any
of the nanoDots. This pre-reading was then subtracted from the final reading after
the exposures were made. A similar setup was used in order to obtain dosimetry
readings for a lateral radiograph on the same polystyrene phantom, see figure 311. Five nanoDots were used at the lateral entrance and exit of the polystyrene
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phantom. Due to the geometry setup, and the fact that the polystyrene blocks
would now be parallel to the x-ray beam, only one nanoDot was placed at midline
in the phantom.

Figure 3-11: Lateral setup for nanoDot measurement on polystyrene phantom.

Again, the system was setup for a 100 cm SID, and 3 exposures were made
at 80kV and 4mAs. 4.5 mm copper BB’s were placed on the entrance side only to
help with location of the nanoDots on the radiographs. One additional copper BB
was placed on the “head” side of the polystyrene phantom entrance in order to
help with position location since the uniformity of the phantom created some initial
confusion with placement in the images.
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Table 3-6: Dose readings from nanoDots taken at 80kV and 4mAs using polystyrene block
phantom for Lateral and AP projections.

Lateral Average Dose

AP Average Dose

(mGy)

(mGy)

Entrance

0.539

0.506

Midline

0.177

0.162

Exit

0.022

0.027

Position

Since the phantom setup was essentially a uniform cube, it is not surprising
that the dose readout for the AP and lateral radiographs were nearly identical. Any
difference in readout from the exposures is most likely due to small variations in
the placement of the dosimeters since the lateral side of the phantom was not
completely flat, as can be seen above in figure 3-11. Of particular interest was the
midline dose from both the AP and lateral exposures. For the AP exposure, the
midline nanoDots were placed perpendicular to the beam axis, whereas in the
lateral setup, the midline nanoDot was placed parallel to the beam axis.
This setup change could not be avoided since the nanoDots were placed
within the stack of polystyrene blocks. If the polystyrene blocks were rotated to
allow for the nanoDots to be place perpendicular to the beam axis, then there
would have been no change in the AP and lateral exposure tests. Having the
nanoDots placed parallel to the beam axis in the for the lateral test presents the
“worst case scenario” as described by Okazaki et al. where the greatest effect of
angle on was seen at 90 and 270 degrees [47]. With an 8.8% difference between
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these two measurements, these results agree with those found in the literature,
however, to minimize the effect of the exposure angle on the any readings, care
will be taken to place the nanoDots at angles as close to 0 degrees as possible
[47], [49], [51], [55].

3.3 Super-Flex Bolus Depth dose
Depth dose measurements allow the physicists to know how the x-ray beam
will attenuate and change as it travels through the medium. As stated previously,
all radiographic equipment tends to vary slightly even within the same
manufacturer and model. Therefore, when

considering dosimetry from

radiographic units, it is necessary to determine how the individual x-ray beam will
interact with tissue. Medical physicists routinely determine dose deposition as a
function of depth using either a water tank or solid phantom to perform depth dose
measurements [27], [56], [57].
For this project, there was a need to perform measurements and
calculations on a range of patient (or phantom) sizes. One way to utilize the current
standard-man-size anthropomorphic phantom for multiple measurements and
calculations is to increase the body habitus by using Super-Flex. Super-Flex Bolus
(Action Products Inc., Hagerstown, MD) is a flexible soft tissue and water
equivalent material commonly used in radiation therapy applications [58]. With its
density of 1.03 g/cm3 Super-flex is also an ideal material to use for diagnostic xray imaging when a tissue equivalent material compensator is needed, with the
range of human soft tissue densities being 0.95g/cm3 (adipose ICRU-44) – 1.06
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g/cm3 (soft tissue ICRU-44) [59]. Using Super-Flex the patient size could be
modified using a single phantom.
Before using the Super-Flex in conjunction with the anthropomorphic
phantom, it was necessary to determine the response and accuracy of the
nanoDots at depth in “tissue”. This would ensure that the response of the nanoDots
with tissue phantom would be consistent to the results observed during the tests
with polystyrene blocks. This experiment was performed by placing nine nanoDots
at various depths within a 12 cm stack of 1 cm pieces of Super-flex. The nanoDots
were arranged at 0 cm (surface), 5 cm, and 10 cm depths, placed 4 cm apart, as
shown in figure 3-12.
The configuration of the nanoDots was chosen as such to obtain depth dose
data both perpendicular and parallel to the tube axis. This technique will compare
the off-axis depth doses ensure that the variations in x-ray beam intensity due to
heal effect are adequately determined and can be accounted for in later
experiments and calculations as necessary. Off-axis in this case referring to the
placement of dosimeters at positions other than just on the central axis, or beam
center, of the phantom.
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Figure 3-12: Placement of nanoDots on Super-flex phantom. nanoDots were placed
parallel and perpendicular to tube axis at the surface, 5cm, and 10cm depth. This figure shows the
nanoDots placed at what will be 10cm depth, with subsequent layers of Super-flex to be placed on
top.

The positions of the nanoDots are labeled as in figure 3-13.

45

Figure 3-13: Layout of nanoDots for off-axis depth dose measurement, with 1 being on the
anode side of the tube and 5 being on the cathode side.

The Super-flex stack was placed directly on the table top, with the imaging
detector in the holder underneath the table. Exposures were made at 80, 100, and
125 kV and 12.5 mAs.
Figures 3-14 – 3-16 show the depth dose data collected for 80 kV, 100 kV
and 125 kV energies.
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Figure 3-14: off axis depth dose data for 80 kV. Anode Cathode axis is in the direction from
position 1 – 5.

Figure 3-15: off axis depth dose data for 100 kV. Anode Cathode axis is in the direction
from position 1 – 5.
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Figure 3-16: off axis depth dose for 125 kV. Anode Cathode axis is in the direction from
position 1 – 5.

These graphs of the off axis depth dose show the slight heel effect as
expected in the anode – cathode direction, as well as a relatively flat response in
the direction perpendicular to the tube axis, at depth for each of the energies.
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4 Monte Carlo testing and validation
1. Programming and testing of Monte Carlo program to use for data
validation and algorithm development.
2. Monte Carlo modeling
a. Using the AK reference point data, the beam characteristic data,
and CT image data sets to perform Monte Carlo simulations.
b. Use GATE to perform simulations using the CT images and
projection radiography data collected on the anthropomorphic and
planar phantoms. GATE is an open-source software developed
using the Geant4 Monte Carlo code dedicated to numerical
simulations in medical imaging and radiotherapy [60].
Monte Carlo simulations have become an essential tool in the design,
optimization and dosimetry in medical physics [60]. Various Monte Carlo
calculation methods have been in use for solving radiation transport problems with
some being developed to simulate photon-electron transport through matter at
energy ranges suitable for medical physics applications [61]. For this project
MCNPX [62], PENELOPE [63], and GEANT4 [64] were considered since they have
been used in diagnostic medical physics applications.
The need was for a Monte Carlo code that would be fairly straightforward to
use and able to utilize an imported CT scan data set as a voxelized phantom.
MCNPX is a very powerful and infinitely customizable program. However, the
programming associated with this code is cumbersome and not entirely utilizable
for diagnostic imaging applications.
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A course entitled “Monte Carlo simulation of x-ray imaging and dosimetry”
held by the European Training and Education for Medical Physics Experts in
Radiology (EUTEMPE-RX) was offered on the use of PENELOPE. This course
was an advanced-introductory course on PENELOPE its theory and uses.
PENELOPE is an excellent Monte Carlo code, highly customizable and fairly
straightforward to use. Unfortunately, there is no readily available way to import
CT data sets into the PENELOPE code.
Lastly,

there

is

the

Monte

Carlo

code

GATE

(http://www.opengatecollaboration.org/#). Programming the code in GATE is
similar to that of PENELOPE, which allowed the utilization of the knowledge
gained at the EUTEMPE-RX course towards the self-start guide for the program.
Additionally, there is a fairly straightforward method to import CT DICOM data sets
into GATE. After a review of the associated literature, and determining it to be a
tested and approved code for medical physics applications GATE was chosen as
the Monte Carlo code to use for this project. One of the main benefits to using
GATE is the ability of the user to import a DICOM CT image dataset by converting
it to an .mhd file using readily available open source image tool kits such as ImageJ
[65] and VV image viewer [66].

4.1 Monte Carlo code
GATE 7.2 was installed in a 64-bit Ubuntu Linux operating system. The
Ubuntu operating system was created in an Oracle virtual machine environment
run on a 64-bit Windows 10 operating system. The Windows 10 operating system
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was installed on an Intel ® Core ™ i5-5300U CPU system with 4 processing cores
and 8.00GB of RAM. The Virtual machine was allotted 2 of the processing cores
and 5.00 GB of RAM.
The main components of the GATE input file are similar to other Monte
Carlo simulation programs in that the user is able to define all aspects of the
simulation, including the radiation source, target, world, and which interactions are
allowed. GATE provides a macro known as the “DoseActor” which stores the
absorbed dose from the simulation in a 3D matrix of the programmers choosing.
The DoseActor can be customized in size and position and attached to any
phantom within the simulation, and allows for the collection of deposited energy
(MeV), absorbed Dose (Gy), the number of hits, and the local statistical uncertainty
[67]. In order to cut down on the simulation time, the DoseActor was modified with
the proven track length estimator (TLE) method available in GATE [67]–[69].

4.2 Accuracy test of Monte Carlo code
In order to test the accuracy of the GATE Monte Carlo software it was
necessary to perform a simulation that could be readily compared to a manual
calculation with a known and accepted value. Given a known problem with a
reference table answer and comparing it to the GATE simulation result will validate
the basic functioning of the Monte Carlo code [60]. The problem chosen for this
test was based on one of the examples found in the text book “The Physics of
Radiology” [42] as follows: “Calculate the exposure per dose for an 80 keV monoenergetic x-ray point source to a point in air”.
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The solution to this problem relies on the relation between the energy
fluence,Ψ, through an area and the exposure X at a point P in the center of the
area. The energy absorbed by a small mass of air at point P is
𝜇𝜇𝑎𝑎𝑎𝑎
Ψ� �
𝜌𝜌 𝑎𝑎𝑎𝑎𝑎𝑎
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Since
1 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 = 0.00873

𝐽𝐽
𝐽𝐽
= �0.00873
𝑅𝑅� 𝑋𝑋
𝑘𝑘𝑔𝑔𝑎𝑎𝑎𝑎𝑎𝑎
𝑘𝑘𝑘𝑘
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Then the energy fluence per Roentgen is
Ψ
𝐽𝐽
= 0.00873 𝜇𝜇
𝑘𝑘𝑘𝑘𝑘𝑘
𝑋𝑋
� 𝜌𝜌𝑎𝑎𝑎𝑎 �
𝑎𝑎𝑎𝑎𝑎𝑎
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For
ℎ𝜐𝜐 = 80 𝑘𝑘𝑘𝑘𝑘𝑘 = 0.08 𝑀𝑀𝑀𝑀𝑀𝑀
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and
𝜇𝜇𝑎𝑎𝑎𝑎
𝑐𝑐𝑚𝑚2
𝑚𝑚2
� � = 0.0236
= 0.00236
𝜌𝜌 𝑎𝑎𝑎𝑎𝑎𝑎
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4-5

the energy fluence is then
Ψ
=
𝑋𝑋

0.00873𝐽𝐽
𝐽𝐽
= 3.6992 2
2
𝑚𝑚
𝑚𝑚 𝑅𝑅
0.00236 � � 𝑘𝑘𝑘𝑘𝑘𝑘
𝑘𝑘𝑘𝑘
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Photon fluence is then
Ψ
Φ
= 𝑋𝑋
𝑋𝑋 ℎ𝜐𝜐
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and
ℎ𝜐𝜐 = 80 𝑘𝑘𝑘𝑘𝑘𝑘 = 1.2816 × 10−14 𝐽𝐽
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Therefore
Φ
3.6992𝐽𝐽
𝑝𝑝ℎ𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜
=
= 2.886 × 1014
−14
2
𝑋𝑋 1.2816 × 10 𝐽𝐽𝑚𝑚 𝑅𝑅
𝑚𝑚2 𝑅𝑅
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𝐽𝐽

The solution is, one needs to have an energy fluence of 3.6992 𝑚𝑚2 for 80 keV
photons of photon fluence 2.886 × 1014
Roentgen at a point, P, in space.

𝑝𝑝ℎ𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜
𝑚𝑚2

to register an exposure of 1

For the GATE simulation, a point source of 80 keV photons was placed at
a distance of 1 meter from the origin. A 1m x 1m x 1cm rectangular prism (slab)
made of dry air was centered at the origin, see figure 4-1.
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Figure 4-1 GATE simulation depicting air slab with point source of 80keV photons
depicted as green lines.

In order to compare the calculation to the results of the simulation, the total
photon fluence at the air slab would need to be simulated. This would entail
performing the GATE simulation for 2.886x1014 photons. This amount of histories
would obviously be time prohibitive and not possible on readily available current
computer systems. Therefore, as is common practice in Monte Carlo simulations,
a smaller number of histories was performed with a factor applied to make up for
the total number of photons required.
10 million histories were simulated and the total dose deposited in the air
slab was tallied. The simulation was performed three different times and an
average dose deposited to the 1m2 air slab was 3.07x10-10 Gy, with an uncertainty
of 0.026. For 1x107 histories, this gives a dose per photon of 3.07x10-17
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𝐺𝐺𝐺𝐺

𝑝𝑝ℎ𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜

in

the simulation. With a photon fluence of 2.89x1014
in the slab can be calculated as follows:
�3.07 × 10−17

𝑝𝑝ℎ𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜
𝑚𝑚2 𝑅𝑅

, the total dose deposited

𝐺𝐺𝐺𝐺
𝑃𝑃ℎ𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜
𝐺𝐺𝐺𝐺
� × �2.89 × 1014
� × 1𝑚𝑚2 = 0.00886
2
𝑝𝑝ℎ𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜
𝑚𝑚 𝑅𝑅
𝑅𝑅
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Per definition, one Roentgen of air kerma deposits 0.00877 Gy in dry air. The
percent difference between this simulation using the GATE code and the known
quantity of Roentgen to gray conversion, was 1.02%.
In addition to this problem, the examples available to all GATE users via the
OpenGATE collaboration website were completed and compared to the results
given by others. These additional examples will not be covered here, but they
serve as a starting point for GATE users to ensure their code is working correctly.

4.3 Super-flex phantom depth dose measurements
In order to ensure the GATE Monte Carlo code would give similar results as
real world measurements, it was necessary to recreate the depth dose experiment
(see chapter 3) in silico. With the nanoDot measurements as reference, and the
physical properties of the Super-Flex well known, the following two experiments
were performed for validation of the GATE Monte Carlo code using a planar
homogeneous phantom setup.
The first experiment was to mock up the entire experiment in GATE by
creating a geometric phantom with the same properties as the Super-flex. This
was accomplished by creating a rectangular prism measuring 25 cm (width) x 30
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cm (length) by 12 cm (height), and giving it the GATE material property of
AT_AG_SI5_14, which has the same material make up and density of the SuperFlex. The source, in this case a point source, was placed at the same SID as used
for the depth dose measurements in the clinic. The source itself posed an issue in
completing this simulation. As with all diagnostic imaging equipment, the x-rays
produced in the clinic are not monoenergetic, but rather, a spectrum of energies
based on the peak energy set on the unit. The general spectrum is the filtered
bremsstrahlung with characteristic peak energies for tungsten as shown in figure
4-2.

Figure 4-2: Filtered bremsstrahlung spectrum with characteristic radiation peaks for
125kVp beam

In order to incorporate the bremsstrahlung spectrum into the Monte Carlo
calculation, the programmer must be able to generate a table that has energy bins
and probability of those energies listed so that the program may produce photon
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histories estimating the x-ray spectrum. Since there is still no practical way to
measure the spectrum in the clinic [39], [61], [70], the spectrum must be generated
via a third party program such as SpekCalc [71]. SpekCalc allows the user to
generate a spectrum for any kVp based on certain details of the x-ray tube, such
as anode angle and various filtration thicknesses.
Since all of the required information may not be available to the physicist to
generate a spectrum in this way, it was necessary to develop a useful method to
model the x-ray beam for future calculations. For this dissertation I chose to use
the equivalent energy, or effective energy, of the x-ray tube for calculation
purposes. The equivalent energy is a way to estimate the quality of a polyenergetic
beam as though it were a monoenergetic beam [42], [45]. The procedure for
determining the equivalent energy is as follows:
The half value layer of the x-ray beam was determined above to be
3.55mmAl. Therefore
𝐻𝐻𝐻𝐻𝐻𝐻 =

0.693
= 3.55 𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 @ 80𝑘𝑘𝑘𝑘
𝜇𝜇
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Where µ is the linear attenuation coefficient of aluminum which is
𝜇𝜇 =

0.693
= 0.1952 𝑚𝑚𝑚𝑚−1
3.55 𝑚𝑚𝑚𝑚

With the density of aluminum being
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4-12

𝜌𝜌𝐴𝐴𝐴𝐴 = 2.699

𝑔𝑔
𝑐𝑐𝑚𝑚3
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The mass attenuation coefficient for this 80kVp beam for aluminum is
𝑚𝑚𝑚𝑚
�0.1952 𝑚𝑚𝑚𝑚−1 � × (10 𝑐𝑐𝑐𝑐 )
𝜇𝜇
1.952 𝑐𝑐𝑚𝑚−1
𝑐𝑐𝑚𝑚2
=
=
=
0.7232
𝑔𝑔
𝑔𝑔
𝜌𝜌𝐴𝐴𝐴𝐴
𝑔𝑔
2.699
2.699
3
𝑐𝑐𝑚𝑚
𝑐𝑐𝑚𝑚3
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We can then use table A-4e in Johns & Cunningham to see that this value
falls between

and

30 𝑘𝑘𝑘𝑘𝑘𝑘 ∶

𝜇𝜇
𝑔𝑔
= 1.101
𝜌𝜌
𝑐𝑐𝑚𝑚2

40 𝑘𝑘𝑘𝑘𝑘𝑘 ∶

𝜇𝜇
𝑔𝑔
= 0.5571
𝜌𝜌
𝑐𝑐𝑚𝑚2
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Using linear interpolation, the result is an equivalent energy of 36.945 keV
for the 80kVp beam with a HVL of 3.55mmAl. Since the HVL can vary over time
due to normal clinical use, the HVL will be measured before each experiment in
the room and a new equivalent energy calculation performed for each Monte Carlo
simulation as needed.
Now that an equivalent energy has been determined, it is necessary to
determine if simulations performed with equivalent energy beams interact in a
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similar manner as the associated spectrum in the Monte Carlo calculation. The
geometric Super-flex phantom simulation was run with both polyenergetic beams
at 80, 100, and 125kVp beams, and the monoenergetic equivalent for each 36.94,
39.51, and 44.39 keV respectively. Depth dose data was taken at 0, 2.5, 4.5, 5.5,
6.5, 8.5, 9.5, and 11.5 cm. The comparison of depth dose ratios are shown in the
following graphs.

Figure 4-3: Monte Carlo depth dose comparison of spectrum and equivalent energy beam
at 80kV.
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Figure 4-4: Monte Carlo depth dose comparison of spectrum and equivalent energy beam
at 100kV.

Figure 4-5: Monte Carlo depth dose comparison of spectrum and equivalent energy beam
at 125kV.
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As can be determined from figures 4-3 – 4-5 above, the equivalent energy
simulation and the spectrum simulation are nearly identical for all energies. It is
interesting to note the deviation observed with the 80kV spectrum at depth greater
than 10 cm. Upon further review of the data generated by SpekCalc for the 80kV
beam, it appears that SpekCalc may have had a rounding error at the high end of
the energy spectrum that caused the simulation to have issues at depth. Additional
spectrum generations for the 80kV beam gave similar results. Given this anomaly,
the fact that the equivalent energy simulation gives nearly identical results, and the
fact that less programming will be needed, thus cutting down on the simulation run
time, all further Monte Carlo calculations for this project will use an equivalent
energy beam for all sources, unless otherwise stated.
The second experiment was to compare the measured doses from the
Super-Flex phantom to calculated doses from GATE simulation using imported CT
scan images of the Super-Flex phantom. The purpose of this experiment was to
ensure that the GATE Monte Carlo software was capable of producing results that
match real-world measurements.
Rather than creating a geometric phantom within GATE for this experiment,
CT images of the Super-Flex phantom were imported into the software using VV.
VV allows utilization of actual subject images in GATE simulations by converting
DICOM data into .mhd image files. DICOM CT images of the Super-Flex phantom
discussed in chapter 2 were obtained on the Siemens Definition AS CT scanner
located at the University of New Mexico Hospital in the advanced imaging suite.
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Figure 4-6: Axial CT image of Super-Flex phantom for use in GATE simulation.

The rest of the GATE simulation recreated lab conditions as accurately as
possible. Equivalent energy monoenergetic x-rays were used in place of spectrum
data, for reasons discussed previously. Depth dose data was collected by placing
a calculation point voxel that encompasses the same volume as the nanoDot
dosimeters, with dimensions 4.43x4.43x0.3 mm. GATE simulated data was then
compared to measured data as depicted in the following graphs.
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Figure 4-7 a-c: Depth dose comparison between measured and GATE simulation
homogeneous Super-Flex phantom. Measured and simulated doses were normalized to maximum
dose, which was at the surface of the phantom.

The agreement (all results within the average 12% uncertainty of the
nanoDot measurements) between the GATE simulated depth dose data and the
nanoDot measured data indicates that GATE will be a good surrogate for dose
measurements in homogenous material.

4.4 Inhomogeneous planar phantom testing
After completing the depth dose measurements and simulations, it was
necessary to determine if the Monte Carlo code would perform as accurately when
faced with an inhomogeneous phantom. An inhomogeneous phantom was created
by stacking polystyrene (density of 1.04 g/cm3) and Styrofoam blocks (density of
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0.05 g/cm3) in a planar phantom. Two phantoms were created: A “large” and
“small” inhomogeneous phantom of polystyrene and Styrofoam. The large
phantom consisted of a total of 16 cm of Styrofoam blocks stacked between two 4
cm stacks of polystyrene with a total height of 24 cm. The “small” phantom
consisted of 8 cm of Styrofoam blocks between two 8 cm stacks of polystyrene for
a total height of 24 cm. See figure 4-8 for both phantoms.

Figure 4-8: Inhomogeneous phantom setup. "Large" phantom on the left consists of 16 cm
of Styrofoam (blue blocks) and 8 cm of polystyrene (clear blocks). "Small" phantom on the right
consists of 8 cm of Styrofoam and 16 cm of polystyrene.

For both phantoms nanoDot dosimeters were placed at the entrance (top)
to the phantom directly on the first set of polystyrene blocks, then at each
Styrofoam surface interface, and finally at the exit (bottom). A total of nine nanoDot
dosimeters were used for the large phantom, and 6 for the small phantom. This
allowed for the collection of depth dose data in a non-homogeneous phantom.
Dose data was collected for 80, 100, 120kV beams. Additionally, CT scans were
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performed of each phantom and the subsequent images were imported into the
GATE simulation.

Figure 4-9: Axial CT images of "Large" (left) and "small" (Right) polystyrene and Styrofoam
phantom. Large and small referring to the amount of Styrofoam present per phantom.

GATE simulations were run for each of the phantoms at each equivalent
energy (36.56, 39.54, 43.51 keV respectively) at each measured depth.
Comparison of depth dose data for each energy are shown below.
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Figure 4-10a-f: Depth dose comparison between measured and GATE simulation in the
Large and Small inhomogeneous phantom. Measured and simulated doses were normalized to
max dose which was at the surface of the phantom.
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Simulated versus measured doses show very good (all results within the
average 12% uncertainty of the nanoDot measurements) agreement for this
inhomogeneous phantom at each energy tested.
The next type of inhomogeneous planar phantom tested incorporated
aluminum plates in addition to the Styrofoam and polystyrene blocks. Two
phantoms were created using 1 mm aluminum plates. The first inhomogeneous
phantom was created by stacking polystyrene and Styrofoam blocks in a planar
phantom, with one of two 1 mm aluminum plates each located between the
Styrofoam and polystyrene blocks. The second phantom was created by using the
same setup as the first with the exception of removing all Styrofoam and replacing
with polystyrene. See figure below for setup.
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Figure 4-11: Inhomogeneous phantom incorporating aluminum plates with polystyrene and
Styrofoam (left), or just polystyrene (right). Their associated CT scans are shown below the images
respectively.

Dose measurements for both of these phantoms were taken at the entrance
(top) of the polystyrene, after the first aluminum plate, before the second aluminum
plate, and at the exit (bottom) of the phantom. See figure 4-11 for CT scans
depicting the phantom setup. GATE simulations were run using at equivalent
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energies for 80, 100 and 120kV as with the previous phantom. Graphs of the
results are shown below.
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Figure 4-12 a-f: Depth dose comparison between measured and GATE simulation in the
Inhomogeneous phantom containing polystyrene, Styrofoam and aluminum, or just polystyrene and
aluminum. Measured and simulated doses were normalized to maximum dose which was at the
surface of the phantom.
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The results obtained from the homogeneous and inhomogeneous
phantoms in the above experiments prove the validity of using GATE Monte Carlo
code as a surrogate to measured data for the rest of this project. This will allow for
the calculation of dose points in both phantoms and decedent subjects without
having to implant dosimeters.
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5 In situ measurements

1. Dosimetry measurements with nanoDots and anthropomorphic phantom to
compile a standard data set for use in algorithm development and
validation.
2. Dose measurements on decedents during PA and Lateral chest
radiographs using nanoDots at the New Mexico Office of the Medical
Investigator (OMI). Obtain radiographs and CT image data sets for use in
algorithm development and Monte Carlo simulations.
3. Perform Monte Carlo simulations for validation of algorithm on varying body
habitus and body weight and height.
4. Compare results from measured phantom data to Monte Carlo simulations
in order to use Monte Carlo simulation data for future validation of algorithm
without having to perform additional measurements
Most validations of mathematical algorithms or Monte Carlo simulations are
based on dosimetry measurements using anthropomorphic phantoms. Although
convenient, most anthropomorphic phantoms are created to represent the
standard man size (73.2 kg and 178.6cm) which cannot account for variations in
size and body habitus encountered in the clinic. It is imperative that the various
Monte Carlo codes and calculation methods be validated on subjects that are
bigger and smaller than standard man size. Varying body habitus can greatly affect
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patient absorbed dose, and can be detrimental to standard calculation methods
[15], [18].
However, it is not practical to verify dosimetry calculations via
measurements on living patients. In order to ensure accuracy and reproducibility,
measurements should be performed multiple times per patient per imaging
procedure. This would entail exposing multiple patients to unnecessary radiation.
A unique opportunity presents itself at the University of New Mexico Office of the
Medical Investigator (OMI). With approval of the OMI Research Review
Committee, it was possible to perform dosimetry measurements on the decedents
undergoing post mortem examination [72]. Recently, many research projects have
begun using post-mortem subjects for dosimetry studies. The use of cadavers or
decedents allows the researcher to obtain multiple dose measurements on a single
subject without the danger of causing harmful radiation effects [73]–[76]. This
proven in situ dosimetry method allows for validation of Monte Carlo calculations
using non-standard man size subjects, as well as, the new patient specific
dosimetry algorithm proposed by this dissertation.

5.1 Anthropomorphic Phantom Dose Measurements
For the initial phantom portion of this project, radiographs and CT scans
were performed on the Alderson Lung/chest Phantom. The phantom is an
anthropomorphic phantom representing the torso of a male subject that is
approximately 5 feet 9 inches (175 cm) tall and weighing 162 lbs. (73.5 kg). The
materials making up the phantom are equivalent to natural bone and soft tissues
[77]. The intent of this phantom imaging was to give a standard data set in order
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to perform preliminary calculations in a controlled setting. A total of 14 nanoDot
dosimeters were placed on the phantom on the anterior, posterior, right and left
sides as shown in figure 5-1. nanoDot dosimeters were placed as follows: Anterior
– level of thyroid, left, right and center chest. Posterior – back of neck at level of
thyroid, left, right, center of back at level of anterior nanoDots. Left and right lateral
sides – level of axilla, then equidistant center of chest and lower level of chest.
The nanoDot dosimeters were present only for their respective images
(either Anterior-Posterior or Lateral) in order to accurately measure entrance and
exit exposure from both the anterior-posterior and lateral radiographs.

Figure 5-1: Placement of the nanoDot dosimeters on the Alderson chest phantom. 4
nanoDots placed on the anterior and posterior surfaces, 3 nanoDots placed on lateral surfaces.

Due to the radio-transparency of the nanoDot dosimeters, a 0.177 caliber
(4.5 mm) copper coated steel BB was placed in vicinity of the nanoDot. The BB
will allow for the identification of the placement of the nanoDots on the radiographs.
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All positioning and anatomical radiographs were performed by an ASRT
certified and registered radiologic technologist to maintain consistency with clinical
techniques and imaging. The Alderson phantom was positioned as would be done
clinically for an AP supine chest radiograph, and a lateral-supine-cross table
radiograph. The radiographs were performed in this manner to maintain
consistency for the decedent radiographs performed at the OMI. Figure 5-2 shows
the positioning for the both the anterior-posterior and lateral radiographs,
respectively.

Figure 5-2: Clinical setup of the Alderson chest phantom for AP and Lateral radiographs.
For the lateral radiograph, a radio transparent pad was placed underneath the phantom in order to
lift it off the table and prevent any table artifacts in the image.

Both AP and lateral radiographs were performed at the University of New
Mexico Hospital x-ray room 1, using a GE Discovery XR656 digital radiographic
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system. The image technique used was 80 kVp and 4 mAs, large focal spot, with
the x-ray tube positioned at 40 inch source-to-image-distance.
The radiographic AP and lateral images are shown in figure 5-3. Due to
geometric magnification, the BB’s placed on the beam entrance side of the
phantom appear slightly larger than those on the beam exit side of the phantom.

Figure 5-3: AP and lateral radiographs of the Alderson chest phantom. Presence of the
4.5mm BB's shows the general position of the nanoDot dosimeters.
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The collected doses from each point were corrected for number of
exposures and are shown in table 5-1.
Table 5-1: Measured doses at specified positions for both AP and Lateral radiographs.

Position

Dose (mGy)

Thyroid

0.262

Left chest

0.425

Right chest

0.424

Center chest

0.440

Neck back

0.017

Left back

0.047

Right back

0.046

Center back

0.018

Right side
top
Right side
middle
Right side
bottom

2.691
2.364
1.531

Left side top

0.041

Left side
middle
Left side
bottom

0.051
0.026

The collected doses follow expectations for heal effect as well as
attenuation through the phantom.
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5.2 Large Anthropomorphic Phantom (Phantom +5 cm Super-Flex)
In order to ensure that a larger size “patient” data set was available, it was
necessary to create a larger anthropomorphic phantom. This was accomplished
by adding 5 cm of Super-flex bolus to the outside of the Alderson Lung/Chest
phantom. As stated above, Super-flex bolus is a soft tissue equivalent material that
is commonly used for both radiation oncology and diagnostic imaging studies when
additional soft tissue equivalent material compensation is necessary. The larger
phantom setup is shown in figure 5-4

Figure 5-4: Anthropomorphic phantom with 5cm of Super-flex added, and nanoDot
dosimeters in place.
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One of the benefits to creating a larger phantom this way was that nanoDot
dosimeters were also able to be placed at depth; in this case 5 cm below the
surface, in addition to the entrance and exit of the phantom. Again, both AP and
lateral radiographs were performed at the University of New Mexico Hospital x-ray
room 1, using a GE Discovery XR656 digital radiographic system. The image
technique for the AP radiographs was 125 kVp and 6.3 mAs, large focal spot, with
the x-ray tube positioned at 40 inch source-to-image-distance. The lateral
radiographs were performed at 125 kVp and 12.5 mAs. The imaging technique
was adjusted to account for the larger size of the subject, in order to obtain
readable clinical images.
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Figure 5-5: AP and Lateral radiographs of the anthropomorphic phantom with 5cm of
Super-flex added.

Collected doses from the nanoDot dosimeters are shown below in table 5-2.
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Table 5-2: nanoDot Dose readouts from anthropomorphic phantom with additional 5cm of
Super-flex material.

Position
Dose (mGy)
Thyroid Entrance
0.312
Left Chest Entrance
2.198
Center Chest Entrance
2.436
Right Chest Entrance
2.317
Abdomen Entrance
2.761
Thyroid 5cm depth
0.974
Left Chest 5cm Depth
1.520
Center Chest 5cm Depth
1.657
Right Chest 5cm Depth
1.503
Abdomen 5cm Depth
1.686
Neck Back
0.052
Left Center Back
0.088
Center Back
0.049
Right Center Back
0.100

The measured doses for this phantom are higher as expected based on the
increase in kV and mAs from the standard size phantom. Also, the doses collected
from this experiment follow what is expected as far as attenuation through the
subject if the general estimate of tissue having a half value layer of 4 cm at
diagnostic energies, and the AP thickness of the phantom being 28 cm. The
estimate would be for the exit dose to be approximately 0.01 times the entrance
dose. This is a “rule of thumb” estimate only, as it neglects scatter contributions
and other effects of the x-ray beam.
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5.3 Decedent Measurements at the New Mexico Office of the Medical
Investigator
All dosimetry measurements on decedent subjects were performed at the
University of New Mexico Office of the Medical Investigator (OMI). Permission to
perform dosimetry measurements at the OMI was obtained by submission of a
“Request for Review of Research Involving OMI Resources” to Dr. Sarah Lathrop
and the OMI research review committee. After review and acceptance by the
committee, a presentation regarding the research and data collection process was
presented at an OMI Operational Needs Meeting. The purpose of the Operational
Needs meeting presentation was to allow the faculty and staff of the OMI to ask
questions and obtain clarification of the data collection process and the reasons
behind the research. The project was accepted unanimously by both the research
review committee and operational needs meeting attendees.
Before data collection could begin, physics measurements were performed
on the GE AMX-4+ Mobile Radiographic unit available in the forensic pathology
lab of the OMI. The beam characterization measurements were performed as
outlined in section 2.3.1-2.3.2. At 80kVp the half value layer of the GE AMX-4+
was determined to be 3.13 mmAl, and the output was 5.94mR/mAs at 40” SID.
Decedent dosimetry measurements were performed as closely as possible
as described for the anthropomorphic phantom, with the exception of steps taken
for contamination control. There are two modes of operation for the forensic
pathology lab: “Stand Down” and “Autopsy”. During Stand Down, the lab is
considered to be at a level where there is minimal risk of contamination, and
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personal protective equipment (PPE) requirements are at a minimum, consisting
mainly of shoe covers and gloves. All physics measurements of the GE AMX-4+
were performed during Stand Down, and all equipment was decontaminated with
wipes and cleaning solutions available before removing them from the lab.
During Autopsy, the lab is treated as a Biosafety Level 3 (BSL-3) facility.
This includes additional training on PPE (i.e., N-95 mask and respirator fit training),
the use of protective clothing that must not leave the lab, and vaccination
requirements for personnel who will enter the lab during Autopsy [78]. All dosimetry
measurements were performed either directly prior to, or during, Autopsy.
Therefore, BSL-3 safety precautions needed to be observed, which included
considerations to minimize contamination of the nanoDots which needed to be
taken into and out of the lab after being placed on the decedents.
In order to minimize contamination to the nanoDots, they were first wrapped
in Glad Press’n Seal ™, an airtight, liquid tight self-adhesive plastic wrap before
taken into the lab. The nanoDots where then placed on the decedent subject in the
same manner as they were on the anthropomorphic phantom for anterior-posterior
and lateral on entrance and exit surfaces. See figure 5-6 for right lateral entrance
placement of nanoDot dosimeters.
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Figure 5-6: Showing placement of Press'n Seal ™ wrapped nanoDots for right lateral
entrance on decedent at OMI.

Exposures were performed in accordance with the size of the decedent and
techniques were determined by the forensic radiographer. For example, the AP
Chest technique for the decedent in figure 5-7 below was 80kv and 12.5 mAs,
whereas the AP chest technique for the decedent in figure 5-8 was 80kV and 3.2
mAs.
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Figure 5-7: Large decedent, DJS009, male 162.2 cm 97 kg

Figure 5-8: Small decedent, DJS008, female 151.0 cm, 33.2 kg.
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After exposures and radiographic images were complete, the nanoDots
were taken out of the imaging room, where the wrapped dosimeter was cleaned
with disinfecting wipes before the Press’n Seal ™ was removed and the nanoDots
placed in a transport container for removal from the forensic lab. This process was
repeated for all dosimetry measurements performed at the OMI. Once
measurements were completed, anonymized radiographs and CT scans were
collected for use in this project.
CT scans of the relevant anatomy for each decedent were imported into
GATE for dose simulation, see figure 5-9 below. The radiographic unit available at
the OMI is a GE AMX-4 Plus mobile radiographic unit. Physics testing as described
in Chapter 2 was performed on this unit in order to accurately model the x-ray unit
in GATE. Results listed in table 5-3 show decent agreement between the
measured doses and GATE simulations. Accuracy of GATE simulations can be
improved by increasing the number of histories run (10 million histories were run
for this test). Some uncertainty related to positioning of the decedents in the OMI
lab may also contribute to the uncertainty in GATE as the dose point position relies
on recognizable landmarks. These landmarks may not be remain consistent
between radiographic and CT images due to the difficulty associated in positioning
decedent subjects.
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Table 5-3: Comparison of results from decedent measurements and GATE simulations on
associated CT scans.

Decedent

Position

Measured
Dose (mGy)

Unc.

GATE
dose
(mGy)

Unc.

DJS008

Entrance

0.319

0.116

0.362

0.081

DJS008

Exit

0.028

0.127

0.027

0.073

DJS008

Total
deposited

0.437

0.172

0.507

0.109

DJS009

Entrance

1.395

0.114

1.267

0.082

DJS009

Exit

0.024

0.149

0.040

0.268

DJS009

Total
Deposited

0.906

0.187

0.793

0.280
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%
difference

14.8%

13.3%

Figure 5-9: Clockwise from top left, small decedent axial image, large decedent axial
image, large decedent coronal image, small decedent coronal image as depicted in GATE. Note
the white box surrounding all images has the same dimensions (1x1x2m).
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6 Algorithm

Developed in this work is an algorithm to estimate the total absorbed dose
to a subject utilizing image data captured at the time of the exam. The algorithm
steps are as follows:
1. Calculation of the entrance skin dose utilizing the dose correction factor,
which developed and discussed in this chapter.
2. Calculation of the exit skin dose which is an adaptation of the entrance skin
dose formula described above.
3. Calculation of the energy imparted from the entrance and exit skin dose
utilizing the saturated-scatter method.
4. Finally, calculation of the total absorbed dose by combining an estimation
of the subject mass and the energy imparted as described above.

6.1 Information available with newer Digital Radiography systems
Recall that the purpose of this project is to provide a relatively
straightforward, accurate way of providing a patient specific dose estimate based
on physics measurements in the clinic and information available from patient
images. This goal is facilitated on newer radiographic systems where the useful
information is provided by the imaging system. Specifically, new digital radiography
systems provide information related to exposure techniques and other factors that
contribute to patient dose. This information, such as kV, mAs, field size, Exposure
Index, and Dose Area Product can greatly improve the accuracy of dose
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calculations by improving on current calculation methods. Of particular use to the
development of this algorithm were the Exposure Index (EI) and Dose Area
Product (DAP).
GE x-ray systems also report the DAP in dGy-cm2 for each exposure. What
is referred to as dose in this system is really the air kerma integrated over the
exposure field in the plane perpendicular to the beam axis [79]. The air kerma is
the kinetic energy released per unit mass as x-ray photons interact with the air.
Because of beam divergence (field size increasing at distance from source), and
the inverse square law (intensity decreasing at distance from source), the DAP will
remain constant throughout the beam path. As defined, the DAP is the dose in air
without backscatter [80] and therefore must be converted from dose in air to dose
in tissue, which will account for the absorbed dose from primary radiation at the
entrance of the subject

6.2 Dose Equation for Calculating Entrance Dose
When accounting for the entrance skin dose, the calculation is greatly
simplified by the availability of the Dose Area Product. Recall that ESD is
calculated by determining the exposure, in air, at the entrance to the patient. The
exposure at this point is determined by knowing the typical output of the x-ray unit
(in mR/mAs) at a specified point. When multiplied by the mAs set on the unit, and
applying the exposure to dose conversion factor, the AK at the entrance of the
subject can be calculated. On units that provide a DAP, all of these factors are
taken into account and the AK at any point along the beam path can be determined
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once the field size at distance is known. Once the data is gathered, the entrance
dose calculation is performed by the following formula

𝐸𝐸𝐸𝐸𝐸𝐸 = �
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is the ratio of mass energy absorption coefficients for

tissue to air in order to convert the absorbed dose in air to that in tissue based on
the effective energy of the x-ray beam [42]. All mass energy absorption coefficients
are interpolated from NIST available data [59] based on the effective energy of the
x-ray beam as calculated from the measured HVL. The field size at the entrance
of the phantom was calculated by taking the set field size at SID and correcting
back to the entrance of the phantom by using the method of similar triangles. The
dose correction factor is the ratio of the EI and average grayscale value in the
region of interest of the resultant image (equation 6-2).
𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 =

𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺 𝑖𝑖𝑖𝑖 𝑅𝑅𝑅𝑅𝑅𝑅
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6.3 Dose Equation for Calculating Exit Dose
The exit dose is calculated in a similar manner using elements of the ESD
algorithm. Similar to the entrance skin dose calculation with the added
consideration of subject thickness. The exit dose is described by the equation
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Additional factors to the entrance skin dose algorithm are d, the total subject
thickness, and 𝜇𝜇̅ the average linear attenuation coefficient along the beam path.
The linear attenuation coefficient is calculated from mass energy absorption data
and material density data available from NIST [59]. The field size at the exit of the
subject was determined by position of the subject and set field size at SID. For the
12cm

Super-Flex

(homogeneous)

stack,

Large

Inhomogeneous,

Small

Inhomogeneous, the exit field size was equal to the field size at SID since these
phantoms were placed directly on the imaging detector. The same was true for the
Anterior-Posterior image of the anthropomorphic chest phantom. For the lateral
image of the Anthropomorphic Chest, as well as, the AP and lateral image of the
Anthropomorphic Chest with 5cm Super-Flex the exit to detector distance varied
and therefore a similar triangle calculation was performed to account for the
differing exit field sizes.

6.4 Total dose deposited
As discussed in chapter 1, the most common way to perform a dose
calculation for patients of diagnostic radiographic exams is by performing the
entrance skin dose (ESD) calculation, as shown in equation 1-1.
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𝐸𝐸𝐸𝐸𝐸𝐸 =

𝑋𝑋 ∗ 𝑚𝑚𝑚𝑚𝑚𝑚 ∗ 𝐷𝐷2
∗ 𝐵𝐵𝐵𝐵𝐵𝐵
[𝑆𝑆𝑆𝑆𝑆𝑆 − (𝑡𝑡 + 𝑏𝑏)]2

1-1

Once the entrance skin dose is calculated, various weighting factors can be
applied in order to obtain an estimate of whole body effective dose [24]. It is also
well known that in the diagnostic energy range (20keV – 150keV), the peak skin
dose (PSD) occurs at the entrance to the subject [57], [81], [82]. Therefore, it is
common for any dose calculation to end with equation 1-1 as a measure of the
highest dose delivered to the patient.
Although the entrance skin dose may be the peak dose received by the
patient, it is important to note that the underlying organ doses, and therefore whole
body effective dose, are not readily determined from the ESD[83]. It is therefore
acceptable to look for the integral dose, or total energy imparted, in order to gain
a better understanding of the possible effects of the radiation dose on the
individual. The integral dose, ∑, is typically expressed as

𝑑𝑑

Σ = ρ � 𝐷𝐷(𝑥𝑥)𝐴𝐴(𝑥𝑥)𝑑𝑑𝑑𝑑

6-4

0

Where x is the depth in the phantom along the central beam axis, D(x) is dose at
depth, and A(x) is the area of the radiation field at depth. At diagnostic energies,
electronic equilibrium can be assumed, and absorbed dose at depth x in the
phantom for a monoenergetic beam can be described by
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𝐷𝐷(𝑥𝑥) = 𝜓𝜓

6-5

𝜇𝜇𝑎𝑎𝑎𝑎
𝜇𝜇𝑎𝑎𝑎𝑎
= 𝑁𝑁𝑒𝑒 (−𝜇𝜇𝜇𝜇) ℎ𝜐𝜐
𝜌𝜌
𝜌𝜌

Where 𝜓𝜓 is the energy fluence, which is the product of the total number of photons
at depth, 𝑁𝑁𝑒𝑒 (−𝜇𝜇𝜇𝜇) , and the photon energy ℎ𝜐𝜐, 𝜇𝜇 and

𝜇𝜇𝑎𝑎𝑎𝑎
𝜌𝜌

are the linear attenuation

coefficient and the mass-energy absorption coefficient of the target material
resepectively. Substituting equation 6-4 into 6-3 will give
𝑑𝑑

Σ = ρ � 𝑁𝑁𝑒𝑒 (−𝜇𝜇𝜇𝜇) ℎ𝜐𝜐
0

𝜇𝜇𝑎𝑎𝑎𝑎
𝐴𝐴(𝑥𝑥)𝑑𝑑𝑑𝑑
𝜌𝜌
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Which is the integral dose from primary radiation for a monoenergetic beam in a
phantom of thickness d [42].
The International Council on Radiation Units and measurements (ICRU)
helped to facilitate the calculation of the integral dose by defining it in terms of the
energy imparted:
ε = 𝑅𝑅𝑖𝑖𝑖𝑖 − 𝑅𝑅𝑜𝑜𝑜𝑜𝑜𝑜 + � 𝑄𝑄𝑛𝑛
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𝑛𝑛

Where Rin is the entrance energy, Rout is the energy that leaves the subject,
and ∑Qn is equal to the total release of energies from nuclear transformations [84].
In the diagnostic energy range, ∑Qn is effectively equal to zero [85]. If the energy
imparted and the irradiated mass of the subject are known then the integral dose
is forthcoming.
It is also possible to calculate the energy imparted when an entrance and
exit dose are known. The saturated scatter-method [86] facilitates the calculation
of energy imparted when exit and entrance dose are known and under electronic
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equilibrium conditions of diagnostic imaging. The energy imparted can be
calculated by
𝑑𝑑

𝑆𝑆𝑆𝑆𝑆𝑆 + 𝑥𝑥 2
𝜀𝜀 = 𝜌𝜌𝜌𝜌0 � 𝐷𝐷(𝑥𝑥) �
� 𝑑𝑑𝑑𝑑
𝑆𝑆𝑆𝑆𝑆𝑆
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Where ρ is the density of the subject, A0 is the area of the x-ray field at the entrance,
D(x) is the dose at depth, and d is the total thickness of the subject [83], [87].
Evaluating this integral gives
𝐷𝐷(0) ∗ (𝑆𝑆𝑆𝑆𝑆𝑆)3 𝐷𝐷(𝑑𝑑) ∗ (𝑆𝑆𝑆𝑆𝑆𝑆 + 𝑑𝑑)3
𝜀𝜀 = 𝜌𝜌𝜌𝜌0 �
−
�
3(𝑆𝑆𝑆𝑆𝑆𝑆)2
3(𝑆𝑆𝑆𝑆𝑆𝑆)2
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Equation 6-9 will give the energy imparted when the entrance and exit dose
are known. To calculate the total absorbed dose, it is necessary to divide equation
6-9 by the total mass of the subject in the radiation field. The total mass can be
calculated by determining the volume of material in the beam and multiplying by
the density of the material. Since the x-ray beam is divergent with a square base,
the volume can be calculated by using equation 6-10 for a truncated pyramid as
shown in figure 6-1, where a is the length of the side of the entrance field, b is the
length of the side of the exit field, and h is the thickness of the subject.
𝑉𝑉 =

1 2
(𝑎𝑎 + 𝑎𝑎𝑎𝑎 + 𝑏𝑏 2 ) ∗ ℎ
3
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6-10

Figure 6-1: Diagram of truncated pyramid.

Once these values are known, the integral dose can be calculated by dividing the
energy imparted by the product of the volume and density of the material.
Σ=

𝜀𝜀
𝑉𝑉 ∗ 𝜌𝜌

6-11
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6.5 Examples
Information needed for this calculation is listed in table 6-1 below.
Table 6-1: Factors needed for calculation.

Factor

Collected from

DAP

DICOM data

Field size at SID

DICOM data

SID

DICOM data

Exposure Index (EI)

DICOM data

Detector configuration (table top,
Technologist
chest board, etc.)
Patient thickness

Images and/or technologist

HVL

Physicist

Patient exit to detector distance

Physicist

Average grayscale over region of

Physicist determination from

interest

resultant image

Information collected by physicist is collected and verified upon acceptance
testing of the unit, at annual physics surveys, or when appropriate after service
calls. Therefore, this information is collected and updated on an interval consistent
with medical physics quality control procedures. The majority of the information
needed is collected from the DICOM metadata that is part of the final image.
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Five phantoms were imaged on the GE Discovery XR656 digital
radiographic system using a combination of techniques to give data for the eleven
examples discussed here. The phantoms used were the 12cm Super-Flex
(homogeneous)

stack,

Large

Inhomogeneous,

Small

Inhomogeneous,

Anthropomorphic Chest, and Anthropomorphic Chest with 5cm Super-Flex
phantoms as described in chapters 4 and 5. The 12cm Super-Flex stack, Large
Inhomogeneous, and Small Inhomogeneous phantoms were imaged using
multiple techniques in attempt to test the adaptability of the algorithm to various
technique changes. The Anthropomorphic Chest and Anthropomorphic Chest with
5cm Super-Flex phantoms were imaged by an ASRT certified and registered
radiologic technologist in order to accurately simulate clinical patient image
acquisition.
Each phantom imaging study was performed by measuring the entrance
and exit doses with nanoDot dosimeters. The total absorbed dose according to
nanoDot measurements was then determined by equation 6-10 as described
above. All data as required in table 6-1 above was collected at the time of each
phantom test. The HVL for each set kV of interest was collected initially during
physics testing as described in chapter 3, and tested before each phantom test to
ensure accuracy and continuity of the beam quality of the system. All relevant
distances (SID, patient exit to detector configuration, etc.) were measured at time
of each phantom test to ensure accuracy of the calculation. All images were
annotated with pertinent information and downloaded from PACS as soon as the
imaging test was complete.
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6.6 Results
Results from measurements, “traditional” dose calculations, and new dose
algorithm calculations are listed in the following tables along with associated
uncertainties, and percent differences between each calculation technique when
compared to measured data. To note, there is no measured nanoDot data
available for the Lateral Anthropomorphic Chest with 5cm Super-Flex phantom
even though radiographic images were taken. However, as shown in chapters 4
and 5, it is possible to perform a GATE simulation on Computed tomography
images of the subject and obtain accurate dose data that can be used in place of
measurements. Therefore, the Anthropomorphic Chest with 5cm Super-Flex
phantom images were imported into GATE, and a simulation dose data was used
for comparison to traditional and new calculation methods.
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Table 6-2: Comparison of Measured dose to traditional calculation to new Algorithm calculation for 12cm Super-Flex phantom at multiple kV
settings with constant mAs. Also included are associated uncertainty with each value along with the percent difference from each calculation method
compared to the measured dose.

12cm Super-Flex
80kV
12cm Super-Flex
80kV
12cm Super-Flex
80kV
12cm Super-Flex
100kV
12cm Super-Flex
100kV
12cm Super-Flex
100kV
12cm Super-Flex
120kV
12cm Super-Flex
120kV
12cm Super-Flex
120kV

Measured
Dose (mGy)

Entrance

0.059

0.12

0.053

0.079

0.039

0.122

0.037

0.073

Exit

0.014

0.166

0.010

0.117

0.012

0.122

0.009

0.073

Dose
Deposited

0.084

0.205

0.083

0.141

0.047

0.173

0.052

0.104

Entrance

0.082

0.122

0.083

0.080

0.063

0.122

0.063

0.073

Exit

0.024

0.161

0.017

0.117

0.026

0.122

0.020

0.073

Dose
Deposited

0.104

0.202

0.125

0.142

0.056

0.173

0.074

0.104

Entrance

0.122

0.116

0.124

0.079

0.091

0.122

0.099

0.073

Exit

0.031

0.119

0.038

0.101

0.044

0.122

0.037

0.073

Dose
Deposited

0.166

0.166

0.151

0.129

0.060

0.173

0.098

0.104

Unc.

GATE
(mGy)

Trad.
Calc.
(mGy)

Position

Unc.

%diff

0.7%

19.0%

9.5%

Unc.

% diff

56.6%

59.2%

94.3%

Algorithm
(mGy)

Unc.

% diff

47.2%
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Phantom

33.2%

51.4%

Table 6-3: Comparison of Measured dose to traditional calculation to new Algorithm calculation for Large and Small Inhomogeneous
phantom at multiple kV settings with constant mAs. Also included are associated uncertainty with each value along with the percent difference from
each calculation method compared to the measured dose.

Large Inhom.
80kV
Large Inhom.
80kV
Large Inhom.
80kV
Large Inhom.
100kV
Large Inhom.
100kV
Large Inhom.
100kV
Small Inhom.
80kV
Small Inhom.
80kV
Small Inhom.
80kV
Small Inhom.
100kV
Small Inhom.
100kV
Small Inhom.
100kV

Measured
Dose (mGy)

Entrance

0.071

0.116

0.060

0.056

0.122

0.053

0.073

Exit

0.016

0.129

0.009

0.014

0.122

0.008

0.073

Dose
Deposited

0.029

0.174

0.033

0.020

0.173

0.029

0.104

Entrance

0.104

0.149

0.102

0.090

0.122

0.091

0.073

Exit

0.030

0.134

0.017

0.029

0.122

0.017

0.073

Dose
Deposited

0.030

0.200

0.053

0.020

0.173

0.042

0.104

Entrance

0.074

0.123

0.058

0.056

0.122

0.050

0.073

Exit

0.011

0.236

0.003

0.014

0.122

0.007

0.073

Dose
Deposited

0.041

0.266

0.043

0.020

0.173

0.027

0.104

Entrance

0.113

0.12

0.104

0.090

0.122

0.081

0.073

Exit

0.017

0.114

0.005

0.029

0.122

0.015

0.073

Dose
Deposited

0.063

0.166

0.076

0.020

0.173

0.038

0.104

Unc.

GATE
(mGy)

Trad.
Calc.
(mGy)

Position

Unc.

0.104

0.104

0.114

0.178

% diff

13.2%

54.3%

4.6%

18.8%

Unc.

% diff

34.9%

41.5%

67.3%

103.1%

Algorithm
(mGy)

Unc.

% diff

1.1%
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Phantom

32.7%

38.9%

49.5%

Table 6-4: Comparison of Measured dose to traditional calculation to new Algorithm calculation for Anthropomorphic Chest and
Anthropomorphic Chest with 5cm Super-Flex. Also included are associated uncertainty with each value along with the percent difference from each
calculation method compared to the measured dose. *No measured data was taken for the lateral view of the Antrhopomorphic Chest with 5cm
Super-Flex phantom, GATE simulation data was used instead.

Trad.
Calc.
(mGy)

Position

Measured
Dose (mGy)

Chest AP 80kV

Entrance

0.446

0.114

0.480

0.072

0.410

0.122

0.433

0.073

Chest AP 80kV

Exit
Dose
Deposited
Entrance

0.019

0.138

0.009

0.134

0.027

0.122

0.028

0.073

0.349

0.179

0.397

0.152

0.272

0.173

0.322

0.104

2.364

0.114

2.216

0.073

2.068

0.122

2.358

0.073

Exit
Dose
Deposited

0.051

0.120

0.056

0.124

0.102

0.122

0.052

0.073

0.925

0.166

0.855

0.144

0.727

0.173

0.921

0.104

Entrance

2.436

0.115

2.394

0.071

2.492

0.122

2.304

0.073

Exit

0.049

0.155

0.031

0.118

0.478

0.122

0.216

0.073

Dose
Deposited

1.189

0.193

1.193

0.138

0.566

0.173

1.020

0.104

Entrance

*

*

3.600

0.073

1.132

0.122

3.361

0.073

Exit

*

*

0.160

0.133

0.182

0.122

0.35

0.073

Dose
Deposited

*

*

3.880

0.152

0.934

0.173

3.262

0.104

Chest AP 80kV
Chest Lat 80kV
Chest Lat 80kV
Chest Lat 80kV
Chest 5cm AP
125 kV
Chest 5cm AP
125 kV
Chest 5cm AP
125 kV
Chest 5cm LAT
125 kV*
Chest 5cm LAT
125 kV*
Chest 5cm LAT
125 kV*

Unc.

Unc.

% diff

12.9%

7.8%

0.4%

*

Unc.

% diff

24.9%

23.9%

70.9%

122.4%

Algorithm
(mGy)

Unc.

% diff

8.1%
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GATE
dose
(mGy)

Phantom

0.4%

15.2%

17.3%

Since all organ doses for these experiments are considered to be low, the
constraint for accuracy of the calculated dose as determined by the International
Commission on Radiation Units and Measurements is that an accuracy of 30-50%
is acceptable [88]. As the above tables demonstrate, the new algorithm
consistently provides more accurate total absorbed dose for each phantom model
with less uncertainty than the traditional method for dose calculations. In the case
of the standard man size, and larger man size (Chest phantom plus 5cm SuperFlex) anthropomorphic phantoms the accuracy of the new algorithm exceeds the
expected accuracy.
For the planar phantoms, the discrepancy between the algorithm and
measured doses was to be expected. As discussed below, the greater inaccuracy
seen with the non-anatomical phantoms is largely due to the fact that there is no
anatomy present, and therefore the processing algorithm contributes a greater
error the EI, which in turn, will add to the uncertainty in the algorithm.
This leads to the conclusion that although the dose calculation algorithm
presented here has improved the accuracy for patient dose calculations, it should
not be used with non-anthropomorphic phantoms due to the greater uncertainty
associated with an incorrectly calculated EI.

6.7 Theory
When performing a dose calculation there are three things to consider as
the x-ray beam traverses the subject: beam hardening, attenuation, and scatter
contributions. Each of these considerations will affect the total dose deposited by
either increasing or decreasing the end result [89].
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Beam hardening occurs when a polyenergetic x-ray beam interacts in a
medium, the lower energy x-rays are more readily attenuated, leaving the higher
energy x-rays to continue on. This will result in an overall higher average energy
for the x-ray beam as it traverses the subject [45], [90]. Beam hardening is
accounted for in this algorithm by means of using the equivalent energy for the
specific x-ray unit. As shown in chapter 4, considering the equivalent or effective
energy based on the half value layer of this unit, it is possible to perform these
accurate calculations by accounting for beam hardening prior to the calculation by
using the half value layer to calculate the effective energy of the x-ray beam.
Attenuation is the fractional change in the intensity of the x-ray beam by a
relatively few, but large energy-loss interactions with the subject [33]. For a typical
broad-beam geometry as is present in diagnostic imaging, the attenuation happens
via the exponential equation
𝐼𝐼 = 𝐼𝐼0 𝑒𝑒 −𝜇𝜇𝜇𝜇

6-12

Where d is the thickness of material, and µ is the attenuation coefficient for
the material based on material properties and the energy of the incoming x-ray
photons. For diagnostic energies electronic equilibrium is assumed and the mass
𝜇𝜇𝑎𝑎𝑎𝑎

energy-absorption coefficient,�
coefficient.

𝜌𝜌

�, is used to calculate the linear attenuation

The grayscale of the image is a visual representation based on the number
of photons detected after they have passed through the patient. The differential
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attenuation from the differing tissues help make up the image on the detector and
is dependent on the subject contrast. Subject contrast is based on the fundamental
interactions between the x-ray photons and the object being imaged. Grayscale
mapping occurs based on the number of photons detected in a region after
differential attenuation through the object due to the subject contrast present.
Digital radiography grayscale is displayed as the inverse of the number of photons
detected [45]. That is, the higher the number of photons detected, the lower the
grayscale value, meaning that no detected photons would map to white (high
average grayscale value) and many photons would be black (0 average grayscale
value).
The exposure index (EI) is proportional to detector entrance exposure, and
is typically, depending on manufacturer, a measure of detector entrance dose. For
the GE XR626, dividing the EI by 100 will give the detector entrance dose in
microgray. The EI is calculated by the system and is based on x-ray imaging
techniques, collimation (physical or software), the raw image data, anatomy
segmentation, and calibration of the system. The GE XR626 system performs the
EI calculation based on the “original data” which is the raw data (pixel values read
directly after analogue to digital conversion) with minimal corrections applied. The
corrections applied to the original data image are those for bad pixels, gain offset,
and geometrical distortions. Therefore, no additional image processing is applied
to the image before the EI is calculated. Also, the EI is limited to the value, or
region, of interest which is limited by segmentation to the anatomy of the image,
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and therefore any empty background of the detector (black space) will not affect
the EI.
The average grayscale value and the EI are related to the absorbed dose
in the region of interest which includes scatter and primary beam components. The
average grayscale for the region of interest is determined by analyzing the image
in a software program, such as ImageJ [65], [91]. As stated, the region of interest
for the image is determined by the proprietary processing algorithms of the vendor,
however, it is possible to hypothesize where the region of interest will be based on
the processing algorithm chosen by the technologist. In the case of figure 6-2
below, the technologist has chosen an AP chest processing algorithm, therefore
the region of interest can generally be described by the yellow box as depicted.

Figure 6-2: Chest AP phantom image. Yellow outline depicts the selected region of
interest for average grayscale value.
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Using these values in equation 6-1 will yield the entrance skin dose in mGy
for the patient based on the selected image.
The region of interest for each processing algorithm is determined by a
proprietary method that is vendor specific. For the GE Discovery XR656
radiographic system used for this project, the region of interest is identified through
image processing techniques that segment out relevant anatomic data based on
the processing algorithm and view chosen. For example, in figure 6-2 since an AP
Chest processing algorithm was chosen the image processing will apply an
anatomy segmentation algorithm to look for key anatomical landmarks (i.e., lungs,
heart etc.) and then determine the EI based on the underlying detector exposure
[21]. This method of determining the EI also explains why the homogeneous and
inhomogeneous planar phantoms had less accuracy when using the EI/Grayscale
correction factor. Since the phantoms had no relevant anatomy, but were still
processed under the AP Chest algorithm, the EI was most likely miscalculated and
therefore skewed the resulting dose calculations.

111

6.8 Steps to complete the algorithm for calculation of total absorbed
dose
In order to calculate the total absorbed dose to a patient using radiographic
images, the following steps are performed:
1. Calculation of the entrance dose by applying the ESD formula from this
dissertation as displayed below.
𝐸𝐸𝐸𝐸𝐸𝐸 = �

𝐷𝐷𝐷𝐷𝐷𝐷 𝑚𝑚𝑚𝑚𝑚𝑚 𝑐𝑐𝑚𝑚2
𝜇𝜇𝑎𝑎𝑎𝑎 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
�∗� �
∗ (1 + 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓)
2
𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑎𝑎𝑎𝑎 𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 𝑐𝑐𝑚𝑚
𝜌𝜌 𝑎𝑎𝑎𝑎𝑎𝑎
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This also requires calculation of the dose correction factor developed in this
work by using the exposure index and average grayscale in the formula
provided in 6-2
𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 =

𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼𝐼
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺 𝑖𝑖𝑖𝑖 𝑅𝑅𝑅𝑅𝑅𝑅
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2. Calculation of the exit dose by use of equation 6-3 below
𝐷𝐷𝐷𝐷𝐷𝐷 𝑚𝑚𝑚𝑚𝑚𝑚 𝑐𝑐𝑚𝑚2
𝜇𝜇𝑎𝑎𝑎𝑎 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 = �
�∗� �
∗ (1 + 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑟𝑟) ∗ 𝑒𝑒 −𝜇𝜇�𝑑𝑑
2
𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑎𝑎𝑎𝑎 𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 𝑐𝑐𝑚𝑚
𝜌𝜌 𝑎𝑎𝑎𝑎𝑎𝑎

Where

�

𝜇𝜇𝑎𝑎𝑎𝑎 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
𝜌𝜌

�

𝑎𝑎𝑎𝑎𝑎𝑎

and 𝜇𝜇̅ are determined from NIST attenuation tables and

evaluation of the equivalent energy of the x-ray beam used.

3. Determination of the energy imparted by using the saturated-scatter method
and the entrance and exit doses using equation 6-9
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6-3

𝐷𝐷(0) ∗ (𝑆𝑆𝑆𝑆𝑆𝑆)3 𝐷𝐷(𝑑𝑑) ∗ (𝑆𝑆𝑆𝑆𝑆𝑆 + 𝑑𝑑)3
𝜀𝜀 = 𝜌𝜌𝜌𝜌0 �
−
�
3(𝑆𝑆𝑆𝑆𝑆𝑆)2
3(𝑆𝑆𝑆𝑆𝑆𝑆)2

6-9

4. Calculate the total dose deposited by dividing the energy imparted by the
mass irradiated.
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7 Future work

This dissertation developed a method for performing patient specific dose
calculations that incorporates data provided by the digital images. Future work for
this project should include testing the dose calculation algorithm using additional
anatomical regions, such as pelvis, abdomen, and skull. This project focused on
AP and Lateral chest processing algorithms whereas there are multiple processing
algorithms for each anatomical location. More importantly, application to pediatric
studies should be investigated as pediatric patients have a greater risk associated
with imaging studies.
Additionally, this project focused on one particular model of Digital
Radiographic unit when there are multiple vendors with various processing
methods that should all be tested. More importantly, this research lays the
foundation for an automated process that could take patient images and
automatically calculate patient specific absorbed doses.

114

Appendices

A
B

Sources of uncertainty in measurements and
calculations
Sample GATE .mac file for determination of dose point

115

116
118

Appendix A
Sources of uncertainty in measurements and calculations
Uncertainties for all measurements and calculations were determined by
listing all relevant uncertainties for each measurement or calculation and adding in
quadrature in order to give a total uncertainty as listed in tables and graphs.
Uncertainties associated with nanoDot dosimeters
Coefficient of Variation from readout – specific to each nanoDot readout.
Each nanoDot is read four times to give the final average reading. The CV is
reported as the mean divided by the standard deviation for each nanoDot.
•

Stationary Repeatability – Determined by the manufacturer as
0.0086

•

Accuracy of measurement – Determined by manufacturer and
verified as 0.05

•

Energy dependence – Determined by manufacturer 0.1

•

MicroStar ii Reader PMT – Determined by manufacturer 0.008

•

MicroStar ii Reader Photodiode – Determined by manufacturer 0.013

Uncertainties associated with GATE simulation
Reported uncertainty – Specific to each run. Given as an output file for each
calculated dose point. This uncertainty is calculated as described by Chetty et
al.[92] using the history-by-history method for estimating the statistical uncertainty.
•

Radcal System HVL accuracy – Determined by manufacturer as 0.05
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•

Radcal system Energy Dependence – Determined by manufacturer
as 0.05

Uncertainties associated with traditional calculation
•

Radcal System HVL accuracy – Determined by manufacturer as 0.05

•

Radcal system Energy Dependence – Determined by manufacturer
as 0.05

•

Backscatter factor tables – depending on the source, can have
differences of up to 10% between materials [27]–[29].

Uncertainties associated with Algorithm
•

Radcal System HVL accuracy – Determined by manufacturer as 0.05

•

Radcal system Energy Dependence – Determined by manufacturer
as 0.05

•

GE XR656 Exposure Index Accuracy – 0.05
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Appendix B
Sample GATE .mac file for determination of dose at a point at the surface
of a geometric phantom simulating a 30x12x25cm block of tissue equivalent
material. This .mac file was adapted from examples provided by OpenGATE
collaboration [93].
#=====================================================
# Adapted from opengate collaboration by Daniel Sandoval
# for dissertation March 2018
#=====================================================

#=====================================================
# VERBOSITY
#=====================================================

/control/execute mac/verbose.mac

#=====================================================
# VISUALISATION
#=====================================================
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/control/execute mac/visu.mac

#=====================================================
# GEOMETRY
#=====================================================

/gate/geometry/setMaterialDatabase data/GateMaterials.db

# World
/gate/world/setMaterial

Air

/gate/world/geometry/setXLength

2.0 m

/gate/world/geometry/setYLength

4.0 m

/gate/world/geometry/setZLength

2.0 m

/vis/scene/add/axes
/vis/scene/add/scale

# Superflex phantom non-imported images
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/gate/world/daughters/name
/gate/world/daughters/insert

superflexphant
box

/gate/superflexphant/geometry/setXLength 30. cm
/gate/superflexphant/geometry/setYLength 12. cm
/gate/superflexphant/geometry/setZLength 25. cm
/gate/superflexphant/placement/setTranslation 0 -6 0 cm
/gate/superflexphant/setMaterial AT_AG_SI4_14
/gate/superflexphant/vis/setVisible

1

/gate/superflexphant/vis/setColor

white

#=====================================================
# PHYSICS
#=====================================================

/gate/physics/addPhysicsList QGSP_BERT_HP
/gate/physics/addAtomDeexcitation
/gate/physics/addProcess

PhotoElectric

/gate/physics/addProcess

Compton
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/gate/physics/addProcess

RayleighScattering gamma

/gate/physics/processes/PhotoElectric/setModel

PenelopeModel

/gate/physics/processes/Compton/setModel

PenelopeModel

/gate/physics/processes/RayleighScattering/setModel PenelopeModel

/gate/physics/Gamma/SetCutInRegion

superflexphant 1.0 mm

/gate/physics/Electron/SetCutInRegion superflexphant 1.0 mm
/gate/physics/Positron/SetCutInRegion superflexphant 1.0 mm

/gate/physics/ActivateSpecialCuts e-

#=====================================================
# DETECTORS
#=====================================================

# ---------------------------------------------------# the following actor regularly store the current number of
# event/track/step in a file
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/gate/actor/addActor

SimulationStatisticActor stat

/gate/actor/stat/saveEveryNSeconds 600

/gate/actor/addActor
/gate/actor/1tle/attachTo

TLEDoseActor 1tle
superflexphant

/gate/actor/1tle/stepHitType
/gate/actor/1tle/setSize

random
4.43 0.3 4.43 mm

/gate/actor/1tle/setVoxelSize
/gate/actor/1tle/setPosition

4.43 0.3 4.43 mm
0 -5.985 0 cm

/gate/actor/1tle/enableDose

true

/gate/actor/1tle/enableUncertaintyDose true
/gate/actor/1tle/enableEdep

true

/gate/actor/1tle/enableUncertaintyEdep true
/gate/actor/1tle/save

output/1TLE-dose.txt

# Set the names of the outputs
/gate/actor/stat/save output/stat.txt
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#=====================================================
# INITIALISATION
#=====================================================

/gate/run/initialize

#=====================================================
# BEAMS
#=====================================================

/gate/source/addSource mybeam gps
/gate/source/mybeam/setIntensity 10.0
/gate/source/mybeam/gps/particle gamma
/gate/source/mybeam/gps/ene/mono 36.98 keV
/gate/source/mybeam/gps/centre

0 -1000 0 mm

/gate/source/mybeam/gps/direction

010

/gate/source/mybeam/gps/pos/type

Point
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/gate/source/mybeam/gps/ang/type

iso

/gate/source/mybeam/gps/ang/mintheta 0. deg
/gate/source/mybeam/gps/ang/maxtheta 13.023 deg
/gate/source/mybeam/gps/ang/minphi

0. deg

/gate/source/mybeam/gps/ang/maxphi

360 deg

/gate/source/mybeam/gps/ang/rot1

100

/gate/source/mybeam/gps/ang/rot2

001

/gate/source/mybeam/gps/pos/rot1

100

/gate/source/mybeam/gps/pos/rot2

001

#=====================================================
# START BEAMS
#=====================================================
/gate/random/setEngineName MersenneTwister
/gate/random/setEngineSeed auto
/gate/application/setTotalNumberOfPrimaries 10
/gate/application/start
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